Loading...

Flora Tassone, PhD

Title(s)Professor, Biochemistry and Molecular Medicine
SchoolUniversity of California, Davis
Address2700 Stockton Blvd
CA 95817
vCardDownload vCard

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Elevated FMR1-mRNA and lowered FMRP - A double-hit mechanism for psychiatric features in men with FMR1 premutations. Transl Psychiatry. 2020 Jun 23; 10(1):205. Schneider A, Winarni TI, Cabal-Herrera AM, Bacalman S, Gane L, Hagerman P, Tassone F, Hagerman R. PMID: 32576818.
      View in: PubMed   Mentions:    Fields:    
    2. Blood-Based Biomarkers Predictive of Metformin Target Engagement in Fragile X Syndrome. Brain Sci. 2020 Jun 10; 10(6). Jasoliya M, Bowling H, Petrasic IC, Durbin-Johnson B, Klann E, Bhattacharya A, Hagerman R, Tassone F. PMID: 32531912.
      View in: PubMed   Mentions:
    3. Controlled trial of lovastatin combined with an open-label treatment of a parent-implemented language intervention in youth with fragile X syndrome. J Neurodev Disord. 2020 Apr 22; 12(1):12. Thurman AJ, Potter LA, Kim K, Tassone F, Banasik A, Potter SN, Bullard L, Nguyen V, McDuffie A, Hagerman R, Abbeduto L. PMID: 32316911.
      View in: PubMed   Mentions: 1     Fields:    
    4. Molecular Biomarkers Predictive of Sertraline Treatment Response in Young Children With Autism Spectrum Disorder. Front Genet. 2020; 11:308. Alolaby RR, Jiraanont P, Durbin-Johnson B, Jasoliya M, Tang HT, Hagerman R, Tassone F. PMID: 32346385.
      View in: PubMed   Mentions:
    5. Parkinsonism Versus Concomitant Parkinson's Disease in Fragile X-Associated Tremor/Ataxia Syndrome. Mov Disord Clin Pract. 2020 May; 7(4):413-418. Salcedo-Arellano MJ, Wolf-Ochoa MW, Hong T, Amina S, Tassone F, Lechpammer M, Hagerman R, Martínez-Cerdeño V. PMID: 32373658.
      View in: PubMed   Mentions:
    6. Rapidly Progressing Neurocognitive Disorder in a Male with FXTAS and Alzheimer's Disease. Clin Interv Aging. 2020; 15:285-292. Aydin EY, Schneider A, Protic D, Wang JY, Martínez-Cerdeño V, Tassone F, Tang HT, Perlman S, Hagerman RJ. PMID: 32161452.
      View in: PubMed   Mentions:    Fields:    
    7. Genetic contributors to risk of schizophrenia in the presence of a 22q11.2 deletion. Mol Psychiatry. 2020 Feb 03. Cleynen I, Engchuan W, Hestand MS, Heung T, Holleman AM, Johnston HR, Monfeuga T, McDonald-McGinn DM, Gur RE, Morrow BE, Swillen A, Vorstman JAS, Bearden CE, Chow EWC, van den Bree M, Emanuel BS, Vermeesch JR, Warren ST, Owen MJ, Chopra P, Cutler DJ, Duncan R, Kotlar AV, Mulle JG, Voss AJ, Zwick ME, Diacou A, Golden A, Guo T, Lin JR, Wang T, Zhang Z, Zhao Y, Marshall C, Merico D, Jin A, Lilley B, Salmons HI, Tran O, Holmans P, Pardinas A, Walters JTR, Demaerel W, Boot E, Butcher NJ, Costain GA, Lowther C, Evers R, van Amelsvoort TAMJ, van Duin E, Vingerhoets C, Breckpot J, Devriendt K, Vergaelen E, Vogels A, Crowley TB, McGinn DE, Moss EM, Sharkus RJ, Unolt M, Zackai EH, Calkins ME, Gallagher RS, Gur RC, Tang SX, Fritsch R, Ornstein C, Repetto GM, Breetvelt E, Duijff SN, Fiksinski A, Moss H, Niarchou M, Murphy KC, Prasad SE, Daly EM, Gudbrandsen M, Murphy CM, Murphy DG, Buzzanca A, Fabio FD, Digilio MC, Pontillo M, Marino B, Vicari S, Coleman K, Cubells JF, Ousley OY, Carmel M, Gothelf D, Mekori-Domachevsky E, Michaelovsky E, Weinberger R, Weizman A, Kushan L, Jalbrzikowski M, Armando M, Eliez S, Sandini C, Schneider M, Béna FS, Antshel KM, Fremont W, Kates WR, Belzeaux R, Busa T, Philip N, Campbell LE, McCabe KL, Hooper SR, Schoch K, Shashi V, Simon TJ, Tassone F, Arango C, Fraguas D, García-Miñaúr S, Morey-Canyelles J, Rosell J, Suñer DH, Raventos-Simic J, Epstein MP, Williams NM, Bassett AS. PMID: 32015465.
      View in: PubMed   Mentions: 1     Fields:    
    8. Developmental aspects of FXAND in a man with the FMR1 premutation. Mol Genet Genomic Med. 2020 Feb; 8(2):e1050. Santos E, Emeka-Nwonovo C, Wang JY, Schneider A, Tassone F, Hagerman P, Hagerman R. PMID: 31899609.
      View in: PubMed   Mentions: 1     Fields:    
    9. Complete Sequence of the 22q11.2 Allele in 1,053 Subjects with 22q11.2 Deletion Syndrome Reveals Modifiers of Conotruncal Heart Defects. Am J Hum Genet. 2020 01 02; 106(1):26-40. Zhao Y, Diacou A, Johnston HR, Musfee FI, McDonald-McGinn DM, McGinn D, Crowley TB, Repetto GM, Swillen A, Breckpot J, Vermeesch JR, Kates WR, Digilio MC, Unolt M, Marino B, Pontillo M, Armando M, Di Fabio F, Vicari S, van den Bree M, Moss H, Owen MJ, Murphy KC, Murphy CM, Murphy D, Schoch K, Shashi V, Tassone F, Simon TJ, Shprintzen RJ, Campbell L, Philip N, Heine-Suñer D, García-Miñaúr S, Fernández L, Bearden CE, Vingerhoets C, van Amelsvoort T, Eliez S, Schneider M, Vorstman JAS, Gothelf D, Zackai E, Agopian AJ, Gur RE, Bassett AS, Emanuel BS, Goldmuntz E, Mitchell LE, Wang T, Morrow BE. PMID: 31870554.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    10. A Randomized Controlled Trial of Sertraline in Young Children With Autism Spectrum Disorder. Front Psychiatry. 2019; 10:810. Potter LA, Scholze DA, Biag HMB, Schneider A, Chen Y, Nguyen DV, Rajaratnam A, Rivera SM, Dwyer PS, Tassone F, Al Olaby RR, Choudhary NS, Salcedo-Arellano MJ, Hagerman RJ. PMID: 31780970.
      View in: PubMed   Mentions:
    11. Interaction between ventricular expansion and structural changes in the corpus callosum and putamen in males with FMR1 normal and premutation alleles. Neurobiol Aging. 2020 02; 86:27-38. Wang JY, Hessl D, Tassone F, Kim K, Hagerman RJ, Rivera SM. PMID: 31733943.
      View in: PubMed   Mentions:    Fields:    
    12. Metformin treatment in young children with fragile X syndrome. Mol Genet Genomic Med. 2019 11; 7(11):e956. Biag HMB, Potter LA, Wilkins V, Afzal S, Rosvall A, Salcedo-Arellano MJ, Rajaratnam A, Manzano-Nunez R, Schneider A, Tassone F, Rivera SM, Hagerman RJ. PMID: 31520524.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    13. The role of AGG interruptions in the FMR1 gene stability: A survey in ethnic groups with low and high rate of consanguinity. Mol Genet Genomic Med. 2019 10; 7(10):e00946. Manor E, Gonen R, Sarussi B, Keidar-Friedman D, Kumar J, Tang HT, Tassone F. PMID: 31453660.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    14. Total and Regional White Matter Lesions Are Correlated With Motor and Cognitive Impairments in Carriers of the FMR1 Premutation. Front Neurol. 2019; 10:832. Hocking DR, Loesch DZ, Trost N, Bui MQ, Hammersley E, Francis D, Tassone F, Storey E. PMID: 31456732.
      View in: PubMed   Mentions:
    15. Fragile X- associated Neuropsychiatric Disorders: A Case Report. Future Neurol. 2019 May; 14(2). Tan MM, Dy JB, Salcedo-Arellano MJ, Tassone F, Hagerman RJ. PMID: 32089651.
      View in: PubMed   Mentions:
    16. Cognitive and behavioral improvement in adults with fragile X syndrome treated with metformin-two cases. Mol Genet Genomic Med. 2019 07; 7(7):e00745. Protic D, Aydin EY, Tassone F, Tan MM, Hagerman RJ, Schneider A. PMID: 31104364.
      View in: PubMed   Mentions: 1     Fields:    
    17. Molecular Biomarkers in Fragile X Syndrome. Brain Sci. 2019 Apr 27; 9(5). Zafarullah M, Tassone F. PMID: 31035599.
      View in: PubMed   Mentions:
    18. Repeat Instability in the Fragile X-Related Disorders: Lessons from a Mouse Model. Brain Sci. 2019 Mar 01; 9(3). Zhao X, Gazy I, Hayward B, Pintado E, Hwang YH, Tassone F, Usdin K. PMID: 30832215.
      View in: PubMed   Mentions:
    19. FMRpolyG alters mitochondrial transcripts level and respiratory chain complex assembly in Fragile X associated tremor/ataxia syndrome [FXTAS]. Biochim Biophys Acta Mol Basis Dis. 2019 06 01; 1865(6):1379-1388. Gohel D, Sripada L, Prajapati P, Singh K, Roy M, Kotadia D, Tassone F, Charlet-Berguerand N, Singh R. PMID: 30771487.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimalsCells
    20. Fragile X-Associated Tremor/Ataxia Syndrome (FXTAS). Methods Mol Biol. 2019; 1942:173-189. Zafarullah M, Tassone F. PMID: 30900185.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimalsCells
    21. Microglial cell activation and senescence are characteristic of the pathology FXTAS. Mov Disord. 2018 12; 33(12):1887-1894. Martínez Cerdeño V, Hong T, Amina S, Lechpammer M, Ariza J, Tassone F, Noctor SC, Hagerman P, Hagerman R. PMID: 30537011.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    22. The Spectrum of Neurological and White Matter Changes and Premutation Status Categories of Older Male Carriers of the FMR1 Alleles Are Linked to Genetic (CGG and FMR1 mRNA) and Cellular Stress (AMPK) Markers. Front Genet. 2018; 9:531. Loesch DZ, Trost N, Bui MQ, Hammersley E, Lay ST, Annesley SJ, Sanislav O, Allan CY, Tassone F, Chen ZP, Ngoei KRW, Kemp BE, Francis D, Fisher PR, Storey E. PMID: 30483310.
      View in: PubMed   Mentions:
    23. Protein synthesis levels are increased in a subset of individuals with fragile X syndrome. Hum Mol Genet. 2018 11 01; 27(21):3825. Jacquemont S, Pacini L, Jønch AE, Cencelli G, Rozenberg I, He Y, D'Andrea L, Pedini G, Eldeeb M, Willemsen R, Gasparini F, Tassone F, Hagerman R, Gomez-Mancilla B, Bagni C. PMID: 30107584.
      View in: PubMed   Mentions:    Fields:    
    24. Increased severity of fragile X spectrum disorders in the agricultural community of Ricaurte, Colombia. Int J Dev Neurosci. 2019 Feb; 72:1-5. Saldarriaga W, Salcedo-Arellano MJ, Rodriguez-Guerrero T, Ríos M, Fandiño-Losada A, Ramirez-Cheyne J, Lein PJ, Tassone F, Hagerman RJ. PMID: 30385191.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    25. Variance of IQ is partially dependent on deletion type among 1,427 22q11.2 deletion syndrome subjects. Am J Med Genet A. 2018 10; 176(10):2172-2181. Zhao Y, Guo T, Fiksinski A, Breetvelt E, McDonald-McGinn DM, Crowley TB, Diacou A, Schneider M, Eliez S, Swillen A, Breckpot J, Vermeesch J, Chow EWC, Gothelf D, Duijff S, Evers R, van Amelsvoort TA, van den Bree M, Owen M, Niarchou M, Bearden CE, Ornstein C, Pontillo M, Buzzanca A, Vicari S, Armando M, Murphy KC, Murphy C, Garcia-Minaur S, Philip N, Campbell L, Morey-Cañellas J, Raventos J, Rosell J, Heine-Suner D, Shprintzen RJ, Gur RE, Zackai E, Emanuel BS, Wang T, Kates WR, Bassett AS, Vorstman JAS, Morrow BE. PMID: 30289625.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    26. Cognitive Deficits and Associated ERP N400 Abnormalities in FXTAS With Parkinsonism. Front Genet. 2018; 9:327. Wang XH, Yang JC, Soohoo R, Cotter D, Yuan M, Xia J, Yaqub S, Doty J, Niu YQ, Tassone F, Hagerman R, Zhang L, Olichney J. PMID: 30279697.
      View in: PubMed   Mentions:
    27. Retraction Notice to: Nested Inversion Polymorphisms Predispose Chromosome 22q11.2 to Meiotic Rearrangements. Am J Hum Genet. 2018 09 06; 103(3):457. Demaerel W, Hestand MS, Vergaelen E, Swillen A, López-Sánchez M, Pérez-Jurado LA, McDonald-McGinn DM, Zackai E, Emanuel BS, Morrow BE, Breckpot J, Devriendt K, Vermeesch JR. PMID: 30193139.
      View in: PubMed   Mentions:    Fields:    
    28. Allopregnanolone Treatment Improves Plasma Metabolomic Profile Associated with GABA Metabolism in Fragile X-Associated Tremor/Ataxia Syndrome: a Pilot Study. Mol Neurobiol. 2019 May; 56(5):3702-3713. Napoli E, Schneider A, Wang JY, Trivedi A, Carrillo NR, Tassone F, Rogawski M, Hagerman RJ, Giulivi C. PMID: 30187385.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCellsCTClinical Trials
    29. Disease-Associated Short Tandem Repeats Co-localize with Chromatin Domain Boundaries. Cell. 2018 09 20; 175(1):224-238.e15. Sun JH, Zhou L, Emerson DJ, Phyo SA, Titus KR, Gong W, Gilgenast TG, Beagan JA, Davidson BL, Tassone F, Phillips-Cremins JE. PMID: 30173918.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    30. Impact of FMR1 Premutation on Neurobehavior and Bioenergetics in Young Monozygotic Twins. Front Genet. 2018; 9:338. Napoli E, Schneider A, Hagerman R, Song G, Wong S, Tassone F, Giulivi C. PMID: 30210529.
      View in: PubMed   Mentions:
    31. Curvilinear Association Between Language Disfluency and FMR1 CGG Repeat Size Across the Normal, Intermediate, and Premutation Range. Front Genet. 2018; 9:344. Klusek J, Porter A, Abbeduto L, Adayev T, Tassone F, Mailick MR, Glicksman A, Tonnsen BL, Roberts JE. PMID: 30197656.
      View in: PubMed   Mentions:
    32. Presence of Middle Cerebellar Peduncle Sign in FMR1 Premutation Carriers Without Tremor and Ataxia. Front Neurol. 2018; 9:695. Famula JL, McKenzie F, McLennan YA, Grigsby J, Tassone F, Hessl D, Rivera SM, Martinez-Cerdeno V, Hagerman RJ. PMID: 30186228.
      View in: PubMed   Mentions:
    33. Assessment of Molecular Measures in Non-FXTAS Male Premutation Carriers. Front Genet. 2018; 9:302. Al Olaby RR, Tang HT, Durbin-Johnson B, Schneider A, Hessl D, Rivera SM, Tassone F. PMID: 30186307.
      View in: PubMed   Mentions:
    34. Evidence for the role of FMR1 gray zone alleles as a risk factor for parkinsonism in females. Mov Disord. 2018 07; 33(7):1178-1181. Loesch DZ, Tassone F, Mellick GD, Horne M, Rubio JP, Bui MQ, Francis D, Storey E. PMID: 30153395.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    35. Middle Cerebellar Peduncle Width-A Novel MRI Biomarker for FXTAS? Front Neurosci. 2018; 12:379. Shelton AL, Wang JY, Fourie E, Tassone F, Chen A, Frizzi L, Hagerman RJ, Ferrer E, Hessl D, Rivera SM. PMID: 29988561.
      View in: PubMed   Mentions:
    36. Protein synthesis levels are increased in a subset of individuals with fragile X syndrome. Hum Mol Genet. 2018 06 15; 27(12):2039-2051. Jacquemont S, Pacini L, Jønch AE, Cencelli G, Rozenberg I, He Y, D'Andrea L, Pedini G, Eldeeb M, Willemsen R, Gasparini F, Tassone F, Hagerman R, Gomez-Mancilla B, Bagni C. PMID: 29590342.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansAnimalsCells
    37. Fentanyl overdose in a female with the FMR1 premutation and FXTAS. J Mol Genet (Isleworth). 2018 Nov; 1(1). El-Deeb M, Adams P, Schneider A, Salcedo-Arellano MJ, Tassone F, Hagerman R. PMID: 31032490.
      View in: PubMed   Mentions:
    38. Age- and CGG repeat-related slowing of manual movement in fragile X carriers: A prodrome of fragile X-associated tremor ataxia syndrome? Mov Disord. 2018 04; 33(4):628-636. Shickman R, Famula J, Tassone F, Leehey M, Ferrer E, Rivera SM, Hessl D. PMID: 29389022.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    39. Genetic cluster of fragile X syndrome in a Colombian district. J Hum Genet. 2018 Apr; 63(4):509-516. Saldarriaga W, Forero-Forero JV, González-Teshima LY, Fandiño-Losada A, Isaza C, Tovar-Cuevas JR, Silva M, Choudhary NS, Tang HT, Aguilar-Gaxiola S, Hagerman RJ, Tassone F. PMID: 29379191.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCellsPHPublic Health
    40. Sindrome X frágil en una Familia Colombiana. Iatreia. 2018 Jan 1; 31(1):76-85. Wilmar Saldarriaga-Gil, Randi Hagerman, Maria Jimena Salcedo, Flora Tassone, Julian Ramirez-Cheyne, Marisol Silva. .
      View in: Publisher Site   Mentions:
    41. A higher rare CNV burden in the genetic background potentially contributes to intellectual disability phenotypes in 22q11.2 deletion syndrome. Eur J Med Genet. 2018 Apr; 61(4):209-212. Jensen M, Kooy RF, Simon TJ, Reyniers E, Girirajan S, Tassone F. PMID: 29191496.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    42. Rare FMR1 gene mutations causing fragile X syndrome: A review. Am J Med Genet A. 2018 01; 176(1):11-18. Sitzmann AF, Hagelstrom RT, Tassone F, Hagerman RJ, Butler MG. PMID: 29178241.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    43. Prenatal Diagnosis of Fragile X: Can a Full Mutation Allele in the FMR1 Gene Contract to a Normal Size? Front Genet. 2017; 8:158. Manor E, Jabareen A, Magal N, Kofman A, Hagerman RJ, Tassone F. PMID: 29163631.
      View in: PubMed   Mentions:
    44. Size and methylation mosaicism in males with Fragile X syndrome. Expert Rev Mol Diagn. 2017 11; 17(11):1023-1032. Jiraanont P, Kumar M, Tang HT, Espinal G, Hagerman PJ, Hagerman RJ, Chutabhakdikul N, Tassone F. PMID: 28929824.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCells
    45. Genome-Wide Association Study to Find Modifiers for Tetralogy of Fallot in the 22q11.2 Deletion Syndrome Identifies Variants in the GPR98 Locus on 5q14.3. Circ Cardiovasc Genet. 2017 Oct; 10(5). Guo T, Repetto GM, McDonald McGinn DM, Chung JH, Nomaru H, Campbell CL, Blonska A, Bassett AS, Chow EWC, Mlynarski EE, Swillen A, Vermeesch J, Devriendt K, Gothelf D, Carmel M, Michaelovsky E, Schneider M, Eliez S, Antonarakis SE, Coleman K, Tomita-Mitchell A, Mitchell ME, Digilio MC, Dallapiccola B, Marino B, Philip N, Busa T, Kushan-Wells L, Bearden CE, Piotrowicz M, Hawula W, Roberts AE, Tassone F, Simon TJ, van Duin EDA, van Amelsvoort TA, Kates WR, Zackai E, Johnston HR, Cutler DJ, Agopian AJ, Goldmuntz E, Mitchell LE, Wang T, Emanuel BS, Morrow BE. PMID: 29025761.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    46. Open-Label Allopregnanolone Treatment of Men with Fragile X-Associated Tremor/Ataxia Syndrome. Neurotherapeutics. 2017 Oct; 14(4):1073-1083. Wang JY, Trivedi AM, Carrillo NR, Yang J, Schneider A, Giulivi C, Adams P, Tassone F, Kim K, Rivera SM, Lubarr N, Wu CY, Irwin RW, Brinton RD, Olichney JM, Rogawski MA, Hagerman RJ. PMID: 28707277.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCTClinical Trials
    47. Fragile X syndrome. Nat Rev Dis Primers. 2017 Sep 29; 3:17065. Hagerman RJ, Berry-Kravis E, Hazlett HC, Bailey DB, Moine H, Kooy RF, Tassone F, Gantois I, Sonenberg N, Mandel JL, Hagerman PJ. PMID: 28960184.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    48. Nested Inversion Polymorphisms Predispose Chromosome 22q11.2 to Meiotic Rearrangements. Am J Hum Genet. 2017 Oct 05; 101(4):616-622. Demaerel W, Hestand MS, Vergaelen E, Swillen A, López-Sánchez M, Pérez-Jurado LA, McDonald-McGinn DM, Zackai E, Emanuel BS, Morrow BE, Breckpot J, Devriendt K, Vermeesch JR. PMID: 28965848.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    49. Metformin as targeted treatment in fragile X syndrome. Clin Genet. 2018 02; 93(2):216-222. Dy ABC, Tassone F, Eldeeb M, Salcedo-Arellano MJ, Tartaglia N, Hagerman R. PMID: 28436599.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansAnimals
    50. Altered expression of the FMR1 splicing variants landscape in premutation carriers. Biochim Biophys Acta Gene Regul Mech. 2017 Nov; 1860(11):1117-1126. Tseng E, Tang HT, AlOlaby RR, Hickey L, Tassone F. PMID: 28888471.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    51. Concomitant occurrence of FXTAS and clinically defined sporadic inclusion body myositis: report of two cases. Croat Med J. 2017 Aug 31; 58(4):310-315. Lechpammer M, Martínez Cerdeno V, Hunsaker MR, Hah M, Gonzales H, Tisch S, Joffe R, Pamphlett R, Tassone F, Hagerman PJ, Bolitho SJ, Hagerman RJ. PMID: 28857524.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    52. A randomized double-blind, placebo-controlled trial of ganaxolone in children and adolescents with fragile X syndrome. J Neurodev Disord. 2017 Aug 02; 9(1):26. Ligsay A, Van Dijck A, Nguyen DV, Lozano R, Chen Y, Bickel ES, Hessl D, Schneider A, Angkustsiri K, Tassone F, Ceulemans B, Kooy RF, Hagerman RJ. PMID: 28764646.
      View in: PubMed   Mentions: 8     Fields:    
    53. Children With Fragile X Syndrome Display Threat-Specific Biases Toward Emotion. Biol Psychiatry Cogn Neurosci Neuroimaging. 2017 09; 2(6):487-492. Burris JL, Barry-Anwar RA, Sims RN, Hagerman RJ, Tassone F, Rivera SM. PMID: 29348038.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    54. Fragile X Newborn Screening: Lessons Learned From a Multisite Screening Study. Pediatrics. 2017 Jun; 139(Suppl 3):S216-S225. Bailey DB, Berry-Kravis E, Gane LW, Guarda S, Hagerman R, Powell CM, Tassone F, Wheeler A. PMID: 28814542.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCellsPHPublic Health
    55. Reduced vagal tone in women with the FMR1 premutation is associated with FMR1 mRNA but not depression or anxiety. J Neurodev Disord. 2017; 9:16. Klusek J, LaFauci G, Adayev T, Brown WT, Tassone F, Roberts JE. PMID: 28469730.
      View in: PubMed   Mentions: 2     Fields:    
    56. Clinical and molecular correlates in fragile X premutation females. eNeurologicalSci. 2017 Jun; 7:49-56. Jiraanont P, Sweha SR, AlOlaby RR, Silva M, Tang HT, Durbin-Johnson B, Schneider A, Espinal GM, Hagerman PJ, Rivera SM, Hessl D, Hagerman RJ, Chutabhakdikul N, Tassone F. PMID: 28971146.
      View in: PubMed   Mentions:
    57. Abnormal trajectories in cerebellum and brainstem volumes in carriers of the fragile X premutation. Neurobiol Aging. 2017 07; 55:11-19. Wang JY, Hessl D, Hagerman RJ, Simon TJ, Tassone F, Ferrer E, Rivera SM. PMID: 28391068.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCells
    58. Molecular analyses of neurogenic defects in a human pluripotent stem cell model of fragile X syndrome. Brain. 2017 03 01; 140(3):582-598. Boland MJ, Nazor KL, Tran HT, Szücs A, Lynch CL, Paredes R, Tassone F, Sanna PP, Hagerman RJ, Loring JF. PMID: 28137726.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansAnimalsCells
    59. Molecular biomarkers predictive of sertraline treatment response in young children with fragile X syndrome. Brain Dev. 2017 Jun; 39(6):483-492. AlOlaby RR, Sweha SR, Silva M, Durbin-Johnson B, Yrigollen CM, Pretto D, Hagerman RJ, Tassone F. PMID: 28242040.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    60. Translation of Expanded CGG Repeats into FMRpolyG Is Pathogenic and May Contribute to Fragile X Tremor Ataxia Syndrome. Neuron. 2017 Jan 18; 93(2):331-347. Sellier C, Buijsen RAM, He F, Natla S, Jung L, Tropel P, Gaucherot A, Jacobs H, Meziane H, Vincent A, Champy MF, Sorg T, Pavlovic G, Wattenhofer-Donze M, Birling MC, Oulad-Abdelghani M, Eberling P, Ruffenach F, Joint M, Anheim M, Martinez-Cerdeno V, Tassone F, Willemsen R, Hukema RK, Viville S, Martinat C, Todd PK, Charlet-Berguerand N. PMID: 28065649.
      View in: PubMed   Mentions: 31     Fields:    Translation:HumansAnimalsCells
    61. Developmental profiles of infants with an FMR1 premutation. J Neurodev Disord. 2016; 8:40. Wheeler AC, Sideris J, Hagerman R, Berry-Kravis E, Tassone F, Bailey DB. PMID: 27822316.
      View in: PubMed   Mentions: 5     Fields:    
    62. Clinical Phenotype of Adult Fragile X Gray Zone Allele Carriers: a Case Series. Cerebellum. 2016 10; 15(5):623-31. Debrey SM, Leehey MA, Klepitskaya O, Filley CM, Shah RC, Kluger B, Berry-Kravis E, Spector E, Tassone F, Hall DA. PMID: 27372099.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCells
    63. Aging in Fragile X Premutation Carriers. Cerebellum. 2016 10; 15(5):587-94. Lozano R, Saito N, Reed D, Eldeeb M, Schneider A, Hessl D, Tassone F, Beckett L, Hagerman R. PMID: 27334385.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    64. Immortalized Parkinson's disease lymphocytes have enhanced mitochondrial respiratory activity. Dis Model Mech. 2016 11 01; 9(11):1295-1305. Annesley SJ, Lay ST, De Piazza SW, Sanislav O, Hammersley E, Allan CY, Francione LM, Bui MQ, Chen ZP, Ngoei KR, Tassone F, Kemp BE, Storey E, Evans A, Loesch DZ, Fisher PR. PMID: 27638668.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCells
    65. Psychiatric disorders among women with the?fragile X premutation without children affected by fragile X syndrome. Am J Med Genet B Neuropsychiatr Genet. 2016 12; 171(8):1139-1147. Gossett A, Sansone S, Schneider A, Johnston C, Hagerman R, Tassone F, Rivera SM, Seritan AL, Hessl D. PMID: 27615674.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    66. Novel Blood Biomarkers Are Associated with White Matter Lesions in Fragile X- Associated Tremor/Ataxia Syndrome. Neurodegener Dis. 2017; 17(1):22-30. Loesch DZ, Annesley SJ, Trost N, Bui MQ, Lay ST, Storey E, De Piazza SW, Sanislav O, Francione LM, Hammersley EM, Tassone F, Francis D, Fisher PR. PMID: 27602566.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    67. Plasma metabolic profile delineates roles for neurodegeneration, pro-inflammatory damage and mitochondrial dysfunction in the FMR1 premutation. Biochem J. 2016 11 01; 473(21):3871-3888. Giulivi C, Napoli E, Tassone F, Halmai J, Hagerman R. PMID: 27555610.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCells
    68. Germinal mosaicism for a deletion of the FMR1 gene leading to fragile X syndrome. Eur J Med Genet. 2016 Sep; 59(9):459-62. Jiraanont P, Hagerman RJ, Neri G, Zollino M, Murdolo M, Tassone F. PMID: 27546052.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    69. Plasma Biomarkers for Monitoring Brain Pathophysiology in FMR1 Premutation Carriers. Front Mol Neurosci. 2016; 9:71. Giulivi C, Napoli E, Tassone F, Halmai J, Hagerman R. PMID: 27570505.
      View in: PubMed   Mentions:
    70. Alcohol use dependence in fragile X syndrome. Intractable Rare Dis Res. 2016 Aug; 5(3):207-13. Salcedo-Arellano MJ, Lozano R, Tassone F, Hagerman RJ, Saldarriaga W. PMID: 27672544.
      View in: PubMed   Mentions:
    71. Down Syndrome and Fragile X Syndrome in a Colombian Woman: Case Report. J Appl Res Intellect Disabil. 2017 Sep; 30(5):970-974. Saldarriaga W, Ruiz FA, Tassone F, Hagerman R. PMID: 27456465.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    72. Clinical and Molecular Assessment in a Female with Fragile X Syndrome and Tuberous Sclerosis. J Genet Disord Genet Rep. 2016; 5(3). Yrigollen CM, Pacini L, Nobile V, Lozano R, Hagerman RJ, Bagni C, Tassone F. PMID: 28232951.
      View in: PubMed   Mentions:
    73. Altered redox mitochondrial biology in the neurodegenerative disorder fragile X-tremor/ataxia syndrome: use of antioxidants in precision medicine. Mol Med. 2016 Oct; 22:548-559. Song G, Napoli E, Wong S, Hagerman R, Liu S, Tassone F, Giulivi C. PMID: 27385396.
      View in: PubMed   Mentions: 6     Fields:    
    74. Broad autism spectrum and obsessive-compulsive symptoms in adults with the fragile X premutation. Clin Neuropsychol. 2016 08; 30(6):929-43. Schneider A, Johnston C, Tassone F, Sansone S, Hagerman RJ, Ferrer E, Rivera SM, Hessl D. PMID: 27355445.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    75. Warburg effect linked to cognitive-executive deficits in FMR1 premutation. FASEB J. 2016 10; 30(10):3334-3351. Napoli E, Song G, Schneider A, Hagerman R, Eldeeb MA, Azarang A, Tassone F, Giulivi C. PMID: 27335370.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    76. Fragile X Mental Retardation Protein (FMRP) controls diacylglycerol kinase activity in neurons. Proc Natl Acad Sci U S A. 2016 06 28; 113(26):E3619-28. Tabet R, Moutin E, Becker JA, Heintz D, Fouillen L, Flatter E, Krezel W, Alunni V, Koebel P, Dembélé D, Tassone F, Bardoni B, Mandel JL, Vitale N, Muller D, Le Merrer J, Moine H. PMID: 27233938.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansAnimalsCells
    77. Premutation in the Fragile X Mental Retardation 1 (FMR1) Gene Affects Maternal Zn-milk and Perinatal Brain Bioenergetics and Scaffolding. Front Neurosci. 2016; 10:159. Napoli E, Ross-Inta C, Song G, Wong S, Hagerman R, Gane LW, Smilowitz JT, Tassone F, Giulivi C. PMID: 27147951.
      View in: PubMed   Mentions:
    78. Role of p53, Mitochondrial DNA Deletions, and Paternal Age in Autism: A Case-Control Study. Pediatrics. 2016 04; 137(4). Wong S, Napoli E, Krakowiak P, Tassone F, Hertz-Picciotto I, Giulivi C. PMID: 27033107.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    79. Finding FMR1 mosaicism in Fragile X syndrome. Expert Rev Mol Diagn. 2016; 16(4):501-7. Gonçalves TF, dos Santos JM, Gonçalves AP, Tassone F, Mendoza-Morales G, Ribeiro MG, Kahn E, Boy R, Pimentel MM, Santos-Rebouças CB. PMID: 26716517.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    80. Phenobarbital use and neurological problems in FMR1 premutation carriers. Neurotoxicology. 2016 Mar; 53:141-147. Saldarriaga W, Lein P, González Teshima LY, Isaza C, Rosa L, Polyak A, Hagerman R, Girirajan S, Silva M, Tassone F. PMID: 26802682.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCells
    81. The Molecular Biology of Premutation Expanded Alleles. . 2016 Jan 1; 101-127. Flora Tassone, Chantal Sellier, Nicolas Charlet-Berguerand, Peter K. Todd. .
      View in: Publisher Site   Mentions:
    82. Genotype/Phenotype Relationships in FXTAS. . 2016 Jan 1; 129-160. Emily G. Allen, Maureen A. Leehey, Flora Tassone, Stephanie Sherman. .
      View in: Publisher Site   Mentions:
    83. The Autism Spectrum Disorders Stem Cell Resource at Children's Hospital of Orange County: Implications for Disease Modeling and Drug Discovery. Stem Cells Transl Med. 2015 Nov; 4(11):1369. Brick DJ, Nethercott HE, Montesano S, Banuelos MG, Stover AE, Schutte SS, O'Dowd DK, Hagerman RJ, Ono M, Hessl DR, Tassone F, Schwartz PH. PMID: 26508786.
      View in: PubMed   Mentions:    Fields:    
    84. Identification of a male with fragile X syndrome through newborn screening. Intractable Rare Dis Res. 2015 Nov; 4(4):198-202. Famula J, Basuta K, Gane LW, Hagerman RJ, Tassone F. PMID: 26668780.
      View in: PubMed   Mentions:
    85. Advanced technologies for the molecular diagnosis of fragile X syndrome. Expert Rev Mol Diagn. 2015; 15(11):1465-73. Tassone F. PMID: 26489042.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCellsPHPublic Health
    86. Axonal neuropathy in female carriers of the fragile X premutation with fragile x-associated tremor ataxia syndrome. Muscle Nerve. 2015 Aug; 52(2):234-9. Ram S, Devapriya IA, Fenton G, Mcvay L, Nguyen DV, Tassone F, Maselli RA, Hagerman RJ. PMID: 25388402.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    87. Anxiety disorders in fragile X premutation carriers: Preliminary characterization of probands and non-probands. Intractable Rare Dis Res. 2015 Aug; 4(3):123-30. Cordeiro L, Abucayan F, Hagerman R, Tassone F, Hessl D. PMID: 26361563.
      View in: PubMed   Mentions:
    88. Dysregulated ADAM10-Mediated Processing of APP during a Critical Time Window Leads to SynapticDeficits in Fragile X Syndrome. Neuron. 2015 Aug 1; 87(4):908. Emanuela Pasciuto, Tariq Ahmed, Tina Wahle, Fabrizio Gardoni, Laura D’Andrea, Laura Pacini, Sébastien Jacquemont, Flora Tassone, Detlef Balschun, Carlos G. Dotti, Zsuzsanna Callaerts-Vegh, Rudi D’Hooge, Ulrike C. Müller, Monica Di Luca, Bart De Strooper, Claudia Bagni. .
      View in: Publisher Site   Mentions:
    89. Mitochondrial Citrate Transporter-dependent Metabolic Signature in the 22q11.2 Deletion Syndrome. J Biol Chem. 2015 Sep 18; 290(38):23240-53. Napoli E, Tassone F, Wong S, Angkustsiri K, Simon TJ, Song G, Giulivi C. PMID: 26221035.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCells
    90. Dysregulated ADAM10-Mediated Processing of APP during a Critical Time Window Leads to Synaptic Deficits in Fragile X Syndrome. Neuron. 2015 Jul 15; 87(2):382-98. Pasciuto E, Ahmed T, Wahle T, Gardoni F, D'Andrea L, Pacini L, Jacquemont S, Tassone F, Balschun D, Dotti CG, Callaerts-Vegh Z, D'Hooge R, Müller UC, Di Luca M, De Strooper B, Bagni C. PMID: 26182420.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansAnimalsCells
    91. Maternal Consequences of the Detection of Fragile X Carriers in Newborn Screening. Pediatrics. 2015 Aug; 136(2):e433-40. Bailey DB, Wheeler A, Berry-Kravis E, Hagerman R, Tassone F, Powell CM, Roche M, Gane LW, Sideris J. PMID: 26169437.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansPHPublic Health
    92. Selected vitamin D metabolic gene variants and risk for autism spectrum disorder in the CHARGE Study. Early Hum Dev. 2015 Aug; 91(8):483-9. Schmidt RJ, Hansen RL, Hartiala J, Allayee H, Sconberg JL, Schmidt LC, Volk HE, Tassone F. PMID: 26073892.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    93. High functioning male with fragile X syndrome and fragile X-associated tremor/ataxia syndrome. Am J Med Genet A. 2015 Sep; 167A(9):2154-61. Basuta K, Schneider A, Gane L, Polussa J, Woodruff B, Pretto D, Hagerman R, Tassone F. PMID: 25920745.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCells
    94. Methadone use in a male with the FMRI premutation and FXTAS. Am J Med Genet A. 2015 Jun; 167(6):1354-9. Muzar Z, Lozano R, Schneider A, Adams PE, Faradz SM, Tassone F, Hagerman RJ. PMID: 25900641.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    95. Molecular diagnosis of Fragile X syndrome in subjects with intellectual disability of unknown origin: implications of its prevalence in regional Pakistan. PLoS One. 2015; 10(4):e0122213. Kanwal M, Alyas S, Afzal M, Mansoor A, Abbasi R, Tassone F, Malik S, Mazhar K. PMID: 25875842.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    96. Temporal dynamics of attentional selection in adult male carriers of the fragile X premutation allele and adult controls. Front Hum Neurosci. 2015; 9:37. Wong LM, Tassone F, Rivera SM, Simon TJ. PMID: 25698960.
      View in: PubMed   Mentions:
    97. Fragile X syndrome. Colomb Med (Cali). 2014 Oct-Dec; 45(4):190-8. Saldarriaga W, Tassone F, González-Teshima LY, Forero-Forero JV, Ayala-Zapata S, Hagerman R. PMID: 25767309.
      View in: PubMed   Mentions: 26     Fields:    Translation:HumansAnimalsCells
    98. A cross-sectional analysis of orienting of visuospatial attention in child and adult carriers of the fragile X premutation. J Neurodev Disord. 2014; 6(1):45. Wong LM, Goodrich-Hunsaker NJ, McLennan YA, Tassone F, Rivera SM, Simon TJ. PMID: 25937844.
      View in: PubMed   Mentions:    Fields:    
    99. Immune mediated disorders in women with a fragile X expansion and FXTAS. Am J Med Genet A. 2015 Jan; 167A(1):190-7. Jalnapurkar I, Rafika N, Tassone F, Hagerman R. PMID: 25399540.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCells
    100. Screening newborn blood spots for 22q11.2 deletion syndrome using multiplex droplet digital PCR. Clin Chem. 2015 Jan; 61(1):182-90. Pretto D, Maar D, Yrigollen CM, Regan J, Tassone F. PMID: 25388430.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCells
    101. Distribution of AGG interruption patterns within nine world populations. Intractable Rare Dis Res. 2014 Nov; 3(4):153-61. Yrigollen CM, Sweha S, Durbin-Johnson B, Zhou L, Berry-Kravis E, Fernandez-Carvajal I, Faradz SM, Amiri K, Shaheen H, Polli R, Murillo-Bonilla L, Silva Arevalo Gde J, Cogram P, Murgia A, Tassone F. PMID: 25606365.
      View in: PubMed   Mentions:
    102. Parent-delivered touchscreen intervention for children with fragile X syndrome. Intractable Rare Dis Res. 2014 Nov; 3(4):166-77. Díez-Juan M, Schneider A, Phillips T, Lozano R, Tassone F, Solomon M, Hagerman RJ. PMID: 25606367.
      View in: PubMed   Mentions:
    103. Differential increases of specific FMR1 mRNA isoforms in premutation carriers. J Med Genet. 2015 Jan; 52(1):42-52. Pretto DI, Eid JS, Yrigollen CM, Tang HT, Loomis EW, Raske C, Durbin-Johnson B, Hagerman PJ, Tassone F. PMID: 25358671.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCells
    104. Mapping the deletion endpoints in individuals with 22q11.2 deletion syndrome by droplet digital PCR. BMC Med Genet. 2014 Oct 14; 15:106. Hwang VJ, Maar D, Regan J, Angkustsiri K, Simon TJ, Tassone F. PMID: 25312060.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCells
    105. The Autism Spectrum Disorders Stem Cell Resource at Children's Hospital of Orange County: Implications for Disease Modeling and Drug Discovery. Stem Cells Transl Med. 2014 Nov; 3(11):1275-86. Brick DJ, Nethercott HE, Montesano S, Banuelos MG, Stover AE, Schutte SS, O'Dowd DK, Hagerman RJ, Ono M, Hessl DR, Tassone F, Schwartz PH. PMID: 25273538.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCellsCTClinical Trials
    106. Clinical and molecular implications of mosaicism in FMR1 full mutations. Front Genet. 2014; 5:318. Pretto D, Yrigollen CM, Tang HT, Williamson J, Espinal G, Iwahashi CK, Durbin-Johnson B, Hagerman RJ, Hagerman PJ, Tassone F. PMID: 25278957.
      View in: PubMed   Mentions:
    107. Decreased DGCR8 expression and miRNA dysregulation in individuals with 22q11.2 deletion syndrome. PLoS One. 2014; 9(8):e103884. Sellier C, Hwang VJ, Dandekar R, Durbin-Johnson B, Charlet-Berguerand N, Ander BP, Sharp FR, Angkustsiri K, Simon TJ, Tassone F. PMID: 25084529.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansCells
    108. AGG interruptions and maternal age affect FMR1 CGG repeat allele stability during transmission. J Neurodev Disord. 2014; 6(1):24. Yrigollen CM, Martorell L, Durbin-Johnson B, Naudo M, Genoves J, Murgia A, Polli R, Zhou L, Barbouth D, Rupchock A, Finucane B, Latham GJ, Hadd A, Berry-Kravis E, Tassone F. PMID: 25110527.
      View in: PubMed   Mentions: 28     Fields:    
    109. The multiple molecular facets of fragile X-associated tremor/ataxia syndrome. J Neurodev Disord. 2014; 6(1):23. Sellier C, Usdin K, Pastori C, Peschansky VJ, Tassone F, Charlet-Berguerand N. PMID: 25161746.
      View in: PubMed   Mentions: 11     Fields:    
    110. Fragile x premutation. J Neurodev Disord. 2014; 6(1):22. Tassone F, Hagerman PJ, Hagerman RJ. PMID: 25170346.
      View in: PubMed   Mentions: 5     Fields:    
    111. Genomic studies in fragile X premutation carriers. J Neurodev Disord. 2014; 6(1):27. Lozano R, Hagerman RJ, Duyzend M, Budimirovic DB, Eichler EE, Tassone F. PMID: 25170347.
      View in: PubMed   Mentions: 10     Fields:    
    112. Group I metabotropic glutamate receptor mediated dynamic immune dysfunction in children with fragile X syndrome. J Neuroinflammation. 2014 Jun 19; 11:110. Careaga M, Noyon T, Basuta K, Van de Water J, Tassone F, Hagerman RJ, Ashwood P. PMID: 24942544.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    113. The development of cognitive control in children with chromosome 22q11.2 deletion syndrome. Front Psychol. 2014; 5:566. Shapiro HM, Tassone F, Choudhary NS, Simon TJ. PMID: 24959159.
      View in: PubMed   Mentions:
    114. Association between macroorchidism and intelligence in FMR1 premutation carriers. Am J Med Genet A. 2014 Sep; 164A(9):2206-11. Lozano R, Summers S, Lozano C, Mu Y, Hessl D, Nguyen D, Tassone F, Hagerman R. PMID: 24903624.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    115. Methylation analysis in newborn screening for fragile X syndrome--reply. JAMA Neurol. 2014 Jun; 71(6):800-1. Tassone F. PMID: 24911127.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansPHPublic Health
    116. Staged transthoracic approach to persistent atrial fibrillation (TOP-AF): study protocol for a randomized trial. Trials. 2014 May 26; 15:190. Pragliola C, Mastroroberto P, Gaudino M, Chello M, Covino E. PMID: 24885377.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    117. Eye movements reveal impaired inhibitory control in adult male fragile X premutation carriers asymptomatic for FXTAS. Neuropsychology. 2014 Jul; 28(4):571-584. Wong LM, Goodrich-Hunsaker NJ, McLennan Y, Tassone F, Zhang M, Rivera SM, Simon TJ. PMID: 24773414.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    118. Immune dysregulation as a cause of autoinflammation in fragile X premutation carriers: link between FMRI CGG repeat number and decreased cytokine responses. PLoS One. 2014; 9(4):e94475. Careaga M, Rose D, Tassone F, Berman RF, Hagerman R, Ashwood P. PMID: 24718368.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansAnimalsCells
    119. CGG allele size somatic mosaicism and methylation in FMR1 premutation alleles. J Med Genet. 2014 May; 51(5):309-18. Pretto DI, Mendoza-Morales G, Lo J, Cao R, Hadd A, Latham GJ, Durbin-Johnson B, Hagerman R, Tassone F. PMID: 24591415.
      View in: PubMed   Mentions: 24     Fields:    Translation:HumansCells
    120. Newborn screening for fragile X syndrome. JAMA Neurol. 2014 Mar; 71(3):355-9. Tassone F. PMID: 24395328.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansPHPublic Health
    121. Memantine for fragile X-associated tremor/ataxia syndrome: a randomized, double-blind, placebo-controlled trial. J Clin Psychiatry. 2014 Mar; 75(3):264-71. Seritan AL, Nguyen DV, Mu Y, Tassone F, Bourgeois JA, Schneider A, Cogswell JB, Cook KR, Leehey MA, Grigsby J, Olichney JM, Adams PE, Legg W, Zhang L, Hagerman PJ, Hagerman RJ. PMID: 24345444.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    122. Psychological status in female carriers of premutation FMR1 allele showing a complex relationship with the size of CGG expansion. Clin Genet. 2015 Feb; 87(2):173-8. Loesch DZ, Bui MQ, Hammersley E, Schneider A, Storey E, Stimpson P, Burgess T, Francis D, Slater H, Tassone F, Hagerman RJ, Hessl D. PMID: 24428240.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansCells
    123. CNS expression of murine fragile X protein (FMRP) as a function of CGG-repeat size. Hum Mol Genet. 2014 Jun 15; 23(12):3228-38. Ludwig AL, Espinal GM, Pretto DI, Jamal AL, Arque G, Tassone F, Berman RF, Hagerman PJ. PMID: 24463622.
      View in: PubMed   Mentions: 31     Fields:    Translation:HumansAnimalsCells
    124. Parkinsonism in fragile X-associated tremor/ataxia syndrome (FXTAS): revisited. Parkinsonism Relat Disord. 2014 Apr; 20(4):456-9. Niu YQ, Yang JC, Hall DA, Leehey MA, Tassone F, Olichney JM, Hagerman RJ, Zhang L. PMID: 24491663.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    125. Altered neural activity in the 'when' pathway during temporal processing in fragile X premutation carriers. Behav Brain Res. 2014 Mar 15; 261:240-8. Kim SY, Tassone F, Simon TJ, Rivera SM. PMID: 24398265.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    126. A Role for MSH2 in the CGG Repeat Expansion. Human Mutation. 2014 Jan 1; 35(1):v-v. Flora Tassone. .
      View in: Publisher Site   Mentions:
    127. Reduced excitatory amino acid transporter 1 and metabotropic glutamate receptor 5 expression in the cerebellum of fragile X mental retardation gene 1 premutation carriers with fragile X-associated tremor/ataxia syndrome. Neurobiol Aging. 2014 May; 35(5):1189-97. Pretto DI, Kumar M, Cao Z, Cunningham CL, Durbin-Johnson B, Qi L, Berman R, Noctor SC, Hagerman RJ, Pessah IN, Tassone F. PMID: 24332449.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    128. FXTAS in an unmethylated mosaic male with fragile X syndrome from Chile. Clin Genet. 2014 Oct; 86(4):378-82. Santa María L, Pugin A, Alliende MA, Aliaga S, Curotto B, Aravena T, Tang HT, Mendoza-Morales G, Hagerman R, Tassone F. PMID: 24028275.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansCells
    129. Offering fragile X syndrome carrier screening: a prospective mixed-methods observational study comparing carrier screening of pregnant and non-pregnant women in the general population. BMJ Open. 2013 Sep 10; 3(9):e003660. Martyn M, Anderson V, Archibald A, Carter R, Cohen J, Delatycki M, Donath S, Emery J, Halliday J, Hill M, Sheffield L, Slater H, Tassone F, Younie S, Metcalfe S. PMID: 24022395.
      View in: PubMed   Mentions: 5     Fields:    
    130. Altered neural activity of magnitude estimation processing in adults with the fragile X premutation. J Psychiatr Res. 2013 Dec; 47(12):1909-16. Kim SY, Hashimoto R, Tassone F, Simon TJ, Rivera SM. PMID: 24045061.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCells
    131. Phenotypes of hypofrontality in older female fragile X premutation carriers. Ann Neurol. 2013 Aug; 74(2):275-83. Yang JC, Simon C, Niu YQ, Bogost M, Schneider A, Tassone F, Seritan A, Grigsby J, Hagerman PJ, Hagerman RJ, Olichney JM. PMID: 23686745.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    132. Fragile X-associated tremor/ataxia syndrome: influence of the FMR1 gene on motor fiber tracts in males with normal and premutation alleles. JAMA Neurol. 2013 Aug; 70(8):1022-9. Wang JY, Hessl D, Schneider A, Tassone F, Hagerman RJ, Rivera SM. PMID: 23753897.
      View in: PubMed   Mentions: 20     Fields:    Translation:HumansCells
    133. A family with two female siblings with compound heterozygous FMR1 premutation alleles. Clin Genet. 2014 May; 85(5):458-63. Basuta K, Lozano R, Schneider A, Yrigollen CM, Hessl D, Hagerman RJ, Tassone F. PMID: 23786467.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    134. High MMP-9 activity levels in fragile X syndrome are lowered by minocycline. Am J Med Genet A. 2013 Aug; 161A(8):1897-903. Dziembowska M, Pretto DI, Janusz A, Kaczmarek L, Leigh MJ, Gabriel N, Durbin-Johnson B, Hagerman RJ, Tassone F. PMID: 23824974.
      View in: PubMed   Mentions: 47     Fields:    Translation:HumansAnimalsCells
    135. Transmission of an FMR1 premutation allele in a large family identified through newborn screening: the role of AGG interruptions. J Hum Genet. 2013 Aug; 58(8):553-9. Yrigollen CM, Mendoza-Morales G, Hagerman R, Tassone F. PMID: 23739124.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCellsPHPublic Health
    136. Intranuclear inclusions in a fragile X mosaic male. Transl Neurodegener. 2013 May 21; 2(1):10. Pretto DI, Hunsaker MR, Cunningham CL, Greco CM, Hagerman RJ, Noctor SC, Hall DA, Hagerman PJ, Tassone F. PMID: 23692864.
      View in: PubMed   Mentions:
    137. Enhanced asynchronous Ca(2+) oscillations associated with impaired glutamate transport in cortical astrocytes expressing Fmr1 gene premutation expansion. J Biol Chem. 2013 May 10; 288(19):13831-41. Cao Z, Hulsizer S, Cui Y, Pretto DL, Kim KH, Hagerman PJ, Tassone F, Pessah IN. PMID: 23553633.
      View in: PubMed   Mentions: 19     Fields:    Translation:AnimalsCells
    138. A randomized double-blind, placebo-controlled trial of minocycline in children and adolescents with fragile x syndrome. J Dev Behav Pediatr. 2013 Apr; 34(3):147-55. Leigh MJ, Nguyen DV, Mu Y, Winarni TI, Schneider A, Chechi T, Polussa J, Doucet P, Tassone F, Rivera SM, Hessl D, Hagerman RJ. PMID: 23572165.
      View in: PubMed   Mentions: 68     Fields:    Translation:Humans
    139. Global increases in both common and rare copy number load associated with autism. Hum Mol Genet. 2013 Jul 15; 22(14):2870-80. Girirajan S, Johnson RL, Tassone F, Balciuniene J, Katiyar N, Fox K, Baker C, Srikanth A, Yeoh KH, Khoo SJ, Nauth TB, Hansen R, Ritchie M, Hertz-Picciotto I, Eichler EE, Pessah IN, Selleck SB. PMID: 23535821.
      View in: PubMed   Mentions: 26     Fields:    Translation:HumansCells
    140. Sequestration of DROSHA and DGCR8 by expanded CGG RNA repeats alters microRNA processing in fragile X-associated tremor/ataxia syndrome. Cell Rep. 2013 Mar 28; 3(3):869-80. Sellier C, Freyermuth F, Tabet R, Tran T, He F, Ruffenach F, Alunni V, Moine H, Thibault C, Page A, Tassone F, Willemsen R, Disney MD, Hagerman PJ, Todd PK, Charlet-Berguerand N. PMID: 23478018.
      View in: PubMed   Mentions: 87     Fields:    Translation:HumansAnimalsCells
    141. Identification of expanded alleles of the FMR1 Gene in the CHildhood Autism Risks from Genes and Environment (CHARGE) study. J Autism Dev Disord. 2013 Mar; 43(3):530-9. Tassone F, Choudhary NS, Tassone F, Durbin-Johnson B, Hansen R, Hertz-Picciotto I, Pessah I. PMID: 22767137.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    142. Fragile X AGG analysis provides new risk predictions for 45-69 repeat alleles. Am J Med Genet A. 2013 Apr; 161A(4):771-8. Nolin SL, Sah S, Glicksman A, Sherman SL, Allen E, Berry-Kravis E, Tassone F, Yrigollen C, Cronister A, Jodah M, Ersalesi N, Dobkin C, Brown WT, Shroff R, Latham GJ, Hadd AG. PMID: 23444167.
      View in: PubMed   Mentions: 43     Fields:    Translation:HumansCells
    143. Prevalence and risk of migraine headaches in adult fragile X premutation carriers. Clin Genet. 2013 Dec; 84(6):546-51. Au J, Akins RS, Berkowitz-Sutherland L, Tang HT, Chen Y, Boyd A, Tassone F, Nguyen DV, Hagerman R. PMID: 23373759.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansCells
    144. Psychiatric features in high-functioning adult brothers with fragile x spectrum disorders. Prim Care Companion CNS Disord. 2013; 15(2). Schneider A, Seritan A, Tassone F, Rivera SM, Hagerman R, Hessl D. PMID: 23930232.
      View in: PubMed   Mentions: 5     Fields:    
    145. New evidence for, and challenges in, linking small CGG repeat expansion FMR1 alleles with Parkinson's disease. Clin Genet. 2013 Oct; 84(4):382-5. Loesch DZ, Tassone F, Lo J, Slater HR, Hills LV, Bui MQ, Silburn PA, Mellick GD. PMID: 23198693.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    146. FMR1 CGG allele size and prevalence ascertained through newborn screening in the United States. Genome Med. 2012; 4(12):100. Tassone F, Iong KP, Tong TH, Lo J, Gane LW, Berry-Kravis E, Nguyen D, Mu LY, Laffin J, Bailey DB, Hagerman RJ. PMID: 23259642.
      View in: PubMed   Mentions: 92     Fields:    
    147. Newborn screening and cascade testing for FMR1 mutations. Am J Med Genet A. 2013 Jan; 161A(1):59-69. Sorensen PL, Gane LW, Yarborough M, Hagerman RJ, Tassone F. PMID: 23239591.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansPHPublic Health
    148. Fragile X syndrome: causes, diagnosis, mechanisms, and therapeutics. J Clin Invest. 2012 Dec; 122(12):4314-22. Bagni C, Tassone F, Neri G, Hagerman R. PMID: 23202739.
      View in: PubMed   Mentions: 79     Fields:    Translation:HumansAnimalsCells
    149. Young adult male carriers of the fragile X premutation exhibit genetically modulated impairments in visuospatial tasks controlled for psychomotor speed. J Neurodev Disord. 2012 Nov 13; 4(1):26. Wong LM, Goodrich-Hunsaker NJ, McLennan Y, Tassone F, Harvey D, Rivera SM, Simon TJ. PMID: 23148490.
      View in: PubMed   Mentions: 9     Fields:    
    150. Fear-specific amygdala function in children and adolescents on the fragile x spectrum: a dosage response of the FMR1 gene. Cereb Cortex. 2014 Mar; 24(3):600-13. Kim SY, Burris J, Bassal F, Koldewyn K, Chattarji S, Tassone F, Hessl D, Rivera SM. PMID: 23146966.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansCells
    151. Newborn, carrier, and early childhood screening recommendations for fragile X. Pediatrics. 2012 Dec; 130(6):1126-35. Abrams L, Cronister A, Brown WT, Tassone F, Sherman SL, Finucane B, McConkie-Rosell A, Hagerman R, Kaufmann WE, Picker J, Coffey S, Skinner D, Johnson V, Miller R, Berry-Kravis E. PMID: 23129072.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansAnimalsCellsPHPublic Health
    152. Male carriers of the FMR1 premutation show altered hippocampal-prefrontal function during memory encoding. Front Hum Neurosci. 2012; 6:297. Wang JM, Koldewyn K, Hashimoto R, Schneider A, Le L, Tassone F, Cheung K, Hagerman P, Hessl D, Rivera SM. PMID: 23115550.
      View in: PubMed   Mentions:
    153. Fragile X-associated tremor/ataxia syndrome (FXTAS) in grey zone carriers. Clin Genet. 2013 Jul; 84(1):74-7. Liu Y, Winarni TI, Zhang L, Tassone F, Hagerman RJ. PMID: 23009394.
      View in: PubMed   Mentions: 26     Fields:    Translation:HumansCells
    154. Sequencing the unsequenceable: expanded CGG-repeat alleles of the fragile X gene. Genome Res. 2013 Jan; 23(1):121-8. Loomis EW, Eid JS, Peluso P, Yin J, Hickey L, Rank D, McCalmon S, Hagerman RJ, Tassone F, Hagerman PJ. PMID: 23064752.
      View in: PubMed   Mentions: 52     Fields:    Translation:HumansCells
    155. Early mitochondrial abnormalities in hippocampal neurons cultured from Fmr1 pre-mutation mouse model. J Neurochem. 2012 Nov; 123(4):613-21. Kaplan ES, Cao Z, Hulsizer S, Tassone F, Berman RF, Hagerman PJ, Pessah IN. PMID: 22924671.
      View in: PubMed   Mentions: 29     Fields:    Translation:HumansAnimalsCells
    156. Neural substrates of executive dysfunction in fragile X-associated tremor/ataxia syndrome (FXTAS): a brain potential study. Cereb Cortex. 2013 Nov; 23(11):2657-66. Yang JC, Chan SH, Khan S, Schneider A, Nanakul R, Teichholtz S, Niu YQ, Seritan A, Tassone F, Grigsby J, Hagerman PJ, Hagerman RJ, Olichney JM. PMID: 22918986.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    157. Immune-mediated disorders among women carriers of fragile X premutation alleles. Am J Med Genet A. 2012 Oct; 158A(10):2473-81. Winarni TI, Chonchaiya W, Sumekar TA, Ashwood P, Morales GM, Tassone F, Nguyen DV, Faradz SM, Van de Water J, Cook K, Hamlin A, Mu Y, Hagerman PJ, Hagerman RJ. PMID: 22903889.
      View in: PubMed   Mentions: 33     Fields:    Translation:HumansCells
    158. Maternal periconceptional folic acid intake and risk of autism spectrum disorders and developmental delay in the CHARGE (CHildhood Autism Risks from Genetics and Environment) case-control study. Am J Clin Nutr. 2012 Jul; 96(1):80-9. Schmidt RJ, Tancredi DJ, Ozonoff S, Hansen RL, Hartiala J, Allayee H, Schmidt LC, Tassone F, Hertz-Picciotto I. PMID: 22648721.
      View in: PubMed   Mentions: 87     Fields:    Translation:Humans
    159. De novo microduplication of the FMR1 gene in a patient with developmental delay, epilepsy and hyperactivity. Eur J Hum Genet. 2012 Nov; 20(11):1197-200. Vengoechea J, Parikh AS, Zhang S, Tassone F. PMID: 22549406.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCells
    160. Hypertension in FMR1 premutation males with and without fragile X-associated tremor/ataxia syndrome (FXTAS). Am J Med Genet A. 2012 Jun; 158A(6):1304-9. Hamlin AA, Sukharev D, Campos L, Mu Y, Tassone F, Hessl D, Nguyen DV, Loesch D, Hagerman RJ. PMID: 22528549.
      View in: PubMed   Mentions: 26     Fields:    Translation:Humans
    161. AGG interruptions within the maternal FMR1 gene reduce the risk of offspring with fragile X syndrome. Genet Med. 2012 Aug; 14(8):729-36. Yrigollen CM, Durbin-Johnson B, Gane L, Nelson DL, Hagerman R, Hagerman PJ, Tassone F. PMID: 22498846.
      View in: PubMed   Mentions: 58     Fields:    Translation:HumansCells
    162. A fragile X sibship from a consanguineous family with a compound heterozygous female and partially methylated full mutation male. Am J Med Genet A. 2012 May; 158A(5):1221-4. Sorensen PL, Basuta K, Mendoza-Morales G, Gane LW, Schneider A, Hagerman R, Tassone F. PMID: 22488807.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    163. Reduced telomere length in individuals with FMR1 premutations and full mutations. Am J Med Genet A. 2012 May; 158A(5):1060-5. Jenkins EC, Tassone F, Ye L, Hoogeveen AT, Brown WT, Hagerman RJ, Hagerman PJ. PMID: 22489017.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    164. Neuropathological, clinical and molecular pathology in female fragile X premutation carriers with and without FXTAS. Genes Brain Behav. 2012 Jul; 11(5):577-85. Tassone F, Greco CM, Hunsaker MR, Seritan AL, Berman RF, Gane LW, Jacquemont S, Basuta K, Jin LW, Hagerman PJ, Hagerman RJ. PMID: 22463693.
      View in: PubMed   Mentions: 49     Fields:    Translation:HumansCells
    165. Age-dependent structural connectivity effects in fragile x premutation. Arch Neurol. 2012 Apr; 69(4):482-9. Wang JY, Hessl DH, Hagerman RJ, Tassone F, Rivera SM. PMID: 22491193.
      View in: PubMed   Mentions: 26     Fields:    Translation:HumansCells
    166. Clustered burst firing in FMR1 premutation hippocampal neurons: amelioration with allopregnanolone. Hum Mol Genet. 2012 Jul 01; 21(13):2923-35. Cao Z, Hulsizer S, Tassone F, Tang HT, Hagerman RJ, Rogawski MA, Hagerman PJ, Pessah IN. PMID: 22466801.
      View in: PubMed   Mentions: 46     Fields:    Translation:AnimalsCells
    167. Altered mTOR signaling and enhanced CYFIP2 expression levels in subjects with fragile X syndrome. Genes Brain Behav. 2012 Apr; 11(3):332-41. Hoeffer CA, Sanchez E, Hagerman RJ, Mu Y, Nguyen DV, Wong H, Whelan AM, Zukin RS, Klann E, Tassone F. PMID: 22268788.
      View in: PubMed   Mentions: 70     Fields:    Translation:HumansCells
    168. The fragile X-associated tremor ataxia syndrome. Results Probl Cell Differ. 2012; 54:337-57. Tassone F, Hagerman R. PMID: 22009361.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansAnimalsCells
    169. Fragile X-associated tremor ataxia syndrome in FMR1 gray zone allele carriers. Mov Disord. 2012 Feb; 27(2):296-300. Hall D, Tassone F, Klepitskaya O, Leehey M. PMID: 22161987.
      View in: PubMed   Mentions: 32     Fields:    Translation:HumansCells
    170. Investigation of amygdala volume in men with the fragile X premutation. Brain Imaging Behav. 2011 Dec; 5(4):285-94. Selmeczy D, Koldewyn K, Wang JM, Lee A, Harvey D, Hessl DR, Tassone F, Adams P, Hagerman RJ, Hagerman PJ, Rivera SM. PMID: 21786216.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    171. Increased prevalence of seizures in boys who were probands with the FMR1 premutation and co-morbid autism spectrum disorder. Hum Genet. 2012 Apr; 131(4):581-9. Chonchaiya W, Au J, Schneider A, Hessl D, Harris SW, Laird M, Mu Y, Tassone F, Nguyen DV, Hagerman RJ. PMID: 22001913.
      View in: PubMed   Mentions: 58     Fields:    Translation:HumansCells
    172. Identification of expanded alleles of the FMR1 gene among high-risk population in Indonesia by using blood spot screening. Genet Test Mol Biomarkers. 2012 Mar; 16(3):162-6. Winarni TI, Utari A, Mundhofir FE, Tong T, Durbin-Johnson B, Faradz SM, Tassone F. PMID: 21988366.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    173. Sleep apnea in fragile X premutation carriers with and without FXTAS. Am J Med Genet B Neuropsychiatr Genet. 2011 Dec; 156B(8):923-8. Hamlin A, Liu Y, Nguyen DV, Tassone F, Zhang L, Hagerman RJ. PMID: 21932336.
      View in: PubMed   Mentions: 27     Fields:    Translation:HumansCells
    174. Fibromyalgia in fragile X mental retardation 1 gene premutation carriers. Rheumatology (Oxford). 2011 Dec; 50(12):2233-6. Leehey MA, Legg W, Tassone F, Hagerman R. PMID: 21926154.
      View in: PubMed   Mentions: 26     Fields:    Translation:Humans
    175. Testing the FMR1 promoter for mosaicism in DNA methylation among CpG sites, strands, and cells in FMR1-expressing males with fragile X syndrome. PLoS One. 2011; 6(8):e23648. Stöger R, Genereux DP, Hagerman RJ, Hagerman PJ, Tassone F, Laird CD. PMID: 21909353.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCells
    176. Widespread non-central nervous system organ pathology in fragile X premutation carriers with fragile X-associated tremor/ataxia syndrome and CGG knock-in mice. Acta Neuropathol. 2011 Oct; 122(4):467-79. Hunsaker MR, Greco CM, Spath MA, Smits AP, Navarro CS, Tassone F, Kros JM, Severijnen LA, Berry-Kravis EM, Berman RF, Hagerman PJ, Willemsen R, Hagerman RJ, Hukema RK. PMID: 21785977.
      View in: PubMed   Mentions: 42     Fields:    Translation:HumansAnimals
    177. Decreased fragile X mental retardation protein expression underlies amygdala dysfunction in carriers of the fragile X premutation. Biol Psychiatry. 2011 Nov 01; 70(9):859-65. Hessl D, Wang JM, Schneider A, Koldewyn K, Le L, Iwahashi C, Cheung K, Tassone F, Hagerman PJ, Rivera SM. PMID: 21783174.
      View in: PubMed   Mentions: 52     Fields:    Translation:Humans
    178. The role of AGG interruptions in the transcription of FMR1 premutation alleles. PLoS One. 2011; 6(7):e21728. Yrigollen CM, Tassone F, Durbin-Johnson B, Tassone F. PMID: 21818263.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansCells
    179. Adult Female Fragile X Premutation Carriers Exhibit Age- and CGG Repeat Length-Related Impairments on an Attentionally Based Enumeration Task. Front Hum Neurosci. 2011; 5:63. Goodrich-Hunsaker NJ, Wong LM, McLennan Y, Tassone F, Harvey D, Rivera SM, Simon TJ. PMID: 21808616.
      View in: PubMed   Mentions:
    180. Prenatal vitamins, one-carbon metabolism gene variants, and risk for autism. Epidemiology. 2011 Jul; 22(4):476-85. Schmidt RJ, Hansen RL, Hartiala J, Allayee H, Schmidt LC, Tancredi DJ, Tassone F, Hertz-Picciotto I. PMID: 21610500.
      View in: PubMed   Mentions: 68     Fields:    Translation:Humans
    181. Enhanced manual and oral motor reaction time in young adult female fragile X premutation carriers. J Int Neuropsychol Soc. 2011 Jul; 17(4):746-50. Goodrich-Hunsaker NJ, Wong LM, McLennan Y, Tassone F, Harvey D, Rivera SM, Simon TJ. PMID: 21554789.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    182. Rare intranuclear inclusions in the brains of 3 older adult males with fragile x syndrome: implications for the spectrum of fragile x-associated disorders. J Neuropathol Exp Neurol. 2011 Jun; 70(6):462-9. Hunsaker MR, Greco CM, Tassone F, Berman RF, Willemsen R, Hagerman RJ, Hagerman PJ. PMID: 21572337.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansCells
    183. High-resolution methylation polymerase chain reaction for fragile X analysis: evidence for novel FMR1 methylation patterns undetected in Southern blot analyses. Genet Med. 2011 Jun; 13(6):528-538. Chen L, Hadd A, Sah S, Houghton JF, Filipovic-Sadic S, Zhang W, Hagerman PJ, Tassone F, Latham GJ. PMID: 21430544.
      View in: PubMed   Mentions: 25     Fields:    Translation:HumansCells
    184. FMR1 gray-zone alleles: association with Parkinson's disease in women? Mov Disord. 2011 Aug 15; 26(10):1900-6. Hall DA, Berry-Kravis E, Zhang W, Tassone F, Spector E, Zerbe G, Hagerman PJ, Ouyang B, Leehey MA. PMID: 21567456.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansCells
    185. A Quantitative Assessment of Tremor and Ataxia in Female FMR1 Premutation Carriers Using CATSYS. Curr Gerontol Geriatr Res. 2011; 2011:484713. Narcisa V, Aguilar D, Nguyen DV, Campos L, Brodovsky J, White S, Adams P, Tassone F, Hagerman PJ, Hagerman RJ. PMID: 23008705.
      View in: PubMed   Mentions:
    186. Fragile x syndrome. Curr Genomics. 2011 May; 12(3):216-24. McLennan Y, Polussa J, Tassone F, Hagerman R. PMID: 22043169.
      View in: PubMed   Mentions:
    187. MAOA, DBH, and SLC6A4 variants in CHARGE: a case-control study of autism spectrum disorders. Autism Res. 2011 Aug; 4(4):250-61. Tassone F, Qi L, Zhang W, Hansen RL, Pessah IN, Hertz-Picciotto I. PMID: 21538940.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    188. Fragile X-associated tremor/ataxia phenotype in a male carrier of unmethylated full mutation in the FMR1 gene. Clin Genet. 2012 Jul; 82(1):88-92. Loesch DZ, Sherwell S, Kinsella G, Tassone F, Taylor A, Amor D, Sung S, Evans A. PMID: 21476992.
      View in: PubMed   Mentions: 32     Fields:    Translation:HumansCells
    189. Diffusion tensor imaging in male premutation carriers of the fragile X mental retardation gene. Mov Disord. 2011 Jun; 26(7):1329-36. Hashimoto R, Srivastava S, Tassone F, Hagerman RJ, Rivera SM. PMID: 21484870.
      View in: PubMed   Mentions: 36     Fields:    Translation:Humans
    190. Differential usage of transcriptional start sites and polyadenylation sites in FMR1 premutation alleles. Nucleic Acids Res. 2011 Aug; 39(14):6172-85. Tassone F, De Rubeis S, Carosi C, La Fata G, Serpa G, Raske C, Willemsen R, Hagerman PJ, Bagni C. PMID: 21478165.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansAnimalsCells
    191. CGG-repeat length threshold for FMR1 RNA pathogenesis in a cellular model for FXTAS. Hum Mol Genet. 2011 Jun 01; 20(11):2161-70. Hoem G, Raske CR, Garcia-Arocena D, Tassone F, Sanchez E, Ludwig AL, Iwahashi CK, Kumar M, Yang JE, Hagerman PJ. PMID: 21389081.
      View in: PubMed   Mentions: 28     Fields:    Translation:HumansCells
    192. A voxel-based morphometry study of grey matter loss in fragile X-associated tremor/ataxia syndrome. Brain. 2011 Mar; 134(Pt 3):863-78. Hashimoto R, Javan AK, Tassone F, Hagerman RJ, Rivera SM. PMID: 21354978.
      View in: PubMed   Mentions: 40     Fields:    Translation:Humans
    193. Clinical phenotypes of a juvenile sibling pair carrying the fragile X premutation. Am J Med Genet A. 2011 Mar; 155A(3):519-25. Basuta K, Narcisa V, Chavez A, Kumar M, Gane L, Hagerman R, Tassone F. PMID: 21344625.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    194. Neuropathologic features in the hippocampus and cerebellum of three older men with fragile X syndrome. Mol Autism. 2011 Feb 08; 2(1):2. Greco CM, Navarro CS, Hunsaker MR, Maezawa I, Shuler JF, Tassone F, Delany M, Au JW, Berman RF, Jin LW, Schumann C, Hagerman PJ, Hagerman RJ. PMID: 21303513.
      View in: PubMed   Mentions: 19     Fields:    
    195. Young adult female fragile X premutation carriers show age- and genetically-modulated cognitive impairments. Brain Cogn. 2011 Apr; 75(3):255-60. Goodrich-Hunsaker NJ, Wong LM, McLennan Y, Srivastava S, Tassone F, Harvey D, Rivera SM, Simon TJ. PMID: 21295394.
      View in: PubMed   Mentions: 34     Fields:    Translation:Humans
    196. Brief report: Sensorimotor gating in idiopathic autism and autism associated with fragile X syndrome. J Autism Dev Disord. 2011 Feb; 41(2):248-53. Yuhas J, Cordeiro L, Tassone F, Ballinger E, Schneider A, Long JM, Ornitz EM, Hessl D. PMID: 20521090.
      View in: PubMed   Mentions: 27     Fields:    Translation:Humans
    197. Mitochondrial dysfunction in autism. JAMA. 2010 Dec 01; 304(21):2389-96. Giulivi C, Zhang YF, Omanska-Klusek A, Ross-Inta C, Wong S, Hertz-Picciotto I, Tassone F, Pessah IN. PMID: 21119085.
      View in: PubMed   Mentions: 125     Fields:    Translation:HumansCells
    198. Prepulse inhibition in patients with fragile X-associated tremor ataxia syndrome. Neurobiol Aging. 2012 Jun; 33(6):1045-53. Schneider A, Ballinger E, Chavez A, Tassone F, Hagerman RJ, Hessl D. PMID: 20961665.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    199. Autoimmune disease in mothers with the FMR1 premutation is associated with seizures in their children with fragile X syndrome. Hum Genet. 2010 Nov; 128(5):539-48. Chonchaiya W, Tassone F, Ashwood P, Hessl D, Schneider A, Campos L, Nguyen DV, Hagerman RJ. PMID: 20809278.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    200. FMR1 gene expansion and scans without evidence of dopaminergic deficits in parkinsonism patients. Parkinsonism Relat Disord. 2010 Nov; 16(9):608-11. Hall DA, Jennings D, Seibyl J, Tassone F, Marek K. PMID: 20702130.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCells
    201. Parkinsonism and cognitive decline in a fragile X mosaic male. Mov Disord. 2010 Jul 30; 25(10):1523-4. Hall D, Pickler L, Riley K, Tassone F, Hagerman R. PMID: 20568092.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    202. An information-rich CGG repeat primed PCR that detects the full range of fragile X expanded alleles and minimizes the need for southern blot analysis. J Mol Diagn. 2010 Sep; 12(5):589-600. Chen L, Hadd A, Sah S, Filipovic-Sadic S, Krosting J, Sekinger E, Pan R, Hagerman PJ, Stenzel TT, Tassone F, Latham GJ. PMID: 20616364.
      View in: PubMed   Mentions: 59     Fields:    Translation:HumansCells
    203. An fMRI study of the prefrontal activity during the performance of a working memory task in premutation carriers of the fragile X mental retardation 1 gene with and without fragile X-associated tremor/ataxia syndrome (FXTAS). J Psychiatr Res. 2011 Jan; 45(1):36-43. Hashimoto R, Backer KC, Tassone F, Hagerman RJ, Rivera SM. PMID: 20537351.
      View in: PubMed   Mentions: 30     Fields:    Translation:Humans
    204. Aging in fragile X syndrome. J Neurodev Disord. 2010 Jun; 2(2):70-76. Utari A, Adams E, Berry-Kravis E, Chavez A, Scaggs F, Ngotran L, Boyd A, Hessl D, Gane LW, Tassone F, Tartaglia N, Leehey MA, Hagerman RJ. PMID: 20585378.
      View in: PubMed   Mentions: 21     Fields:    
    205. Early onset of neurological symptoms in fragile X premutation carriers exposed to neurotoxins. Neurotoxicology. 2010 Aug; 31(4):399-402. Paul R, Pessah IN, Gane L, Ono M, Hagerman PJ, Brunberg JA, Tassone F, Bourgeois JA, Adams PE, Nguyen DV, Hagerman R. PMID: 20466021.
      View in: PubMed   Mentions: 25     Fields:    Translation:Humans
    206. Increased number of sex chromosomes affects height in a nonlinear fashion: a study of 305 patients with sex chromosome aneuploidy. Am J Med Genet A. 2010 May; 152A(5):1206-12. Ottesen AM, Aksglaede L, Garn I, Tartaglia N, Tassone F, Gravholt CH, Bojesen A, Sørensen K, Jørgensen N, Rajpert-De Meyts E, Gerdes T, Lind AM, Kjaergaard S, Juul A. PMID: 20425825.
      View in: PubMed   Mentions: 36     Fields:    Translation:HumansCells
    207. Abnormal N400 word repetition effects in fragile X-associated tremor/ataxia syndrome. Brain. 2010 May; 133(Pt 5):1438-50. Olichney JM, Chan S, Wong LM, Schneider A, Seritan A, Niese A, Yang JC, Laird K, Teichholtz S, Khan S, Tassone F, Hagerman R. PMID: 20410144.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansCells
    208. Clinical involvement in daughters of men with fragile X-associated tremor ataxia syndrome. Clin Genet. 2010 Jul; 78(1):38-46. Chonchaiya W, Nguyen DV, Au J, Campos L, Berry-Kravis EM, Lohse K, Mu Y, Utari A, Hervey C, Wang L, Sorensen P, Cook K, Gane L, Tassone F, Hagerman RJ. PMID: 20497189.
      View in: PubMed   Mentions: 28     Fields:    Translation:Humans
    209. Psychological symptoms correlate with reduced hippocampal volume in fragile X premutation carriers. Am J Med Genet B Neuropsychiatr Genet. 2010 Apr 05; 153B(3):775-85. Adams PE, Adams JS, Nguyen DV, Hessl D, Brunberg JA, Tassone F, Zhang W, Koldewyn K, Rivera SM, Grigsby J, Zhang L, Decarli C, Hagerman PJ, Hagerman RJ. PMID: 19908235.
      View in: PubMed   Mentions: 39     Fields:    Translation:Humans
    210. Sam68 sequestration and partial loss of function are associated with splicing alterations in FXTAS patients. EMBO J. 2010 Apr 07; 29(7):1248-61. Sellier C, Rau F, Liu Y, Tassone F, Hukema RK, Gattoni R, Schneider A, Richard S, Willemsen R, Elliott DJ, Hagerman PJ, Charlet-Berguerand N. PMID: 20186122.
      View in: PubMed   Mentions: 150     Fields:    Translation:HumansAnimalsCells
    211. Methylation of novel markers of fragile X alleles is inversely correlated with FMRP expression and FMR1 activation ratio. Hum Mol Genet. 2010 Apr 15; 19(8):1618-32. Godler DE, Tassone F, Loesch DZ, Taylor AK, Gehling F, Hagerman RJ, Burgess T, Ganesamoorthy D, Hennerich D, Gordon L, Evans A, Choo KH, Slater HR. PMID: 20118148.
      View in: PubMed   Mentions: 27     Fields:    Translation:HumansCells
    212. Plasma cytokine profiles in Fragile X subjects: is there a role for cytokines in the pathogenesis? Brain Behav Immun. 2010 Aug; 24(6):898-902. Ashwood P, Nguyen DV, Hessl D, Hagerman RJ, Tassone F. PMID: 20102735.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    213. A novel FMR1 PCR method for the routine detection of low abundance expanded alleles and full mutations in fragile X syndrome. Clin Chem. 2010 Mar; 56(3):399-408. Filipovic-Sadic S, Sah S, Chen L, Krosting J, Sekinger E, Zhang W, Hagerman PJ, Stenzel TT, Hadd AG, Latham GJ, Tassone F. PMID: 20056738.
      View in: PubMed   Mentions: 92     Fields:    Translation:Humans
    214. Murine hippocampal neurons expressing Fmr1 gene premutations show early developmental deficits and late degeneration. Hum Mol Genet. 2010 Jan 01; 19(1):196-208. Chen Y, Tassone F, Berman RF, Hagerman PJ, Hagerman RJ, Willemsen R, Pessah IN. PMID: 19846466.
      View in: PubMed   Mentions: 81     Fields:    Translation:AnimalsCells
    215. The Molecular Biology of FXTAS. . 2010 Jan 1; 77-93. Flora Tassone, Paul J. Hagerman. .
      View in: Publisher Site   Mentions:
    216. Genotype/Phenotype Relationships in FXTAS. . 2010 Jan 1; 95-122. Emily Allen, Maureen A. Leehey, Flora Tassone, Stephanie Sherman. .
      View in: Publisher Site   Mentions:
    217. Broad clinical involvement in a family affected by the fragile X premutation. J Dev Behav Pediatr. 2009 Dec; 30(6):544-51. Chonchaiya W, Utari A, Pereira GM, Tassone F, Hessl D, Hagerman RJ. PMID: 19996900.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    218. High-risk fragile x screening in Guatemala: use of a new blood spot polymerase chain reaction technique. Genet Test Mol Biomarkers. 2009 Dec; 13(6):855-9. Yuhas J, Walichiewicz P, Pan R, Zhang W, Casillas EM, Hagerman RJ, Tassone F. PMID: 19810826.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    219. Fibroblast phenotype in male carriers of FMR1 premutation alleles. Hum Mol Genet. 2010 Jan 15; 19(2):299-312. Garcia-Arocena D, Yang JE, Brouwer JR, Tassone F, Iwahashi C, Berry-Kravis EM, Goetz CG, Sumis AM, Zhou L, Nguyen DV, Campos L, Howell E, Ludwig A, Greco C, Willemsen R, Hagerman RJ, Hagerman PJ. PMID: 19864489.
      View in: PubMed   Mentions: 32     Fields:    Translation:HumansAnimalsCells
    220. Linking the FMR1 alleles with small CGG expansions with neurodevelopmental disorders: preliminary data suggest an involvement of epigenetic mechanisms. Am J Med Genet A. 2009 Oct; 149A(10):2306-10. Loesch DZ, Godler DE, Khaniani M, Gould E, Gehling F, Dissanayake C, Burgess T, Tassone F, Huggins R, Slater H, Choo KH. PMID: 19760650.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCells
    221. Translation of the FMR1 mRNA is not influenced by AGG interruptions. Nucleic Acids Res. 2009 Nov; 37(20):6896-904. Ludwig AL, Raske C, Tassone F, Garcia-Arocena D, Hershey JW, Hagerman PJ. PMID: 19752155.
      View in: PubMed   Mentions: 9     Fields:    Translation:Cells
    222. Polymerase chain reaction, nuclease digestion, and mass spectrometry based assay for the trinucleotide repeat status of the fragile X mental retardation 1 gene. Anal Chem. 2009 Jul 01; 81(13):5533-40. Dodds ED, Tassone F, Hagerman PJ, Lebrilla CB. PMID: 19514725.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    223. FMR1 premutation in females diagnosed with multiple sclerosis. J Neurol Neurosurg Psychiatry. 2009 Jul; 80(7):812-4. Zhang L, Coffey S, Lua LL, Greco CM, Schafer JA, Brunberg J, Borodyanskaya M, Agius MA, Apperson M, Leehey M, Tartaglia N, Tassone F, Hagerman PJ, Hagerman RJ. PMID: 19531693.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansCells
    224. Expansion of an FMR1 grey-zone allele to a full mutation in two generations. J Mol Diagn. 2009 Jul; 11(4):306-10. Fernandez-Carvajal I, Lopez Posadas B, Pan R, Raske C, Hagerman PJ, Tassone F. PMID: 19525339.
      View in: PubMed   Mentions: 37     Fields:    Translation:HumansCells
    225. A quantitative ELISA assay for the fragile x mental retardation 1 protein. J Mol Diagn. 2009 Jul; 11(4):281-9. Iwahashi C, Tassone F, Hagerman RJ, Yasui D, Parrott G, Nguyen D, Mayeur G, Hagerman PJ. PMID: 19460937.
      View in: PubMed   Mentions: 30     Fields:    Translation:HumansAnimalsCells
    226. Screening for expanded alleles of the FMR1 gene in blood spots from newborn males in a Spanish population. J Mol Diagn. 2009 Jul; 11(4):324-9. Fernandez-Carvajal I, Walichiewicz P, Xiaosen X, Pan R, Hagerman PJ, Tassone F. PMID: 19460941.
      View in: PubMed   Mentions: 77     Fields:    Translation:HumansCells
    227. A review of fragile X premutation disorders: expanding the psychiatric perspective. J Clin Psychiatry. 2009 Jun; 70(6):852-62. Bourgeois JA, Coffey SM, Rivera SM, Hessl D, Gane LW, Tassone F, Greco C, Finucane B, Nelson L, Berry-Kravis E, Grigsby J, Hagerman PJ, Hagerman RJ. PMID: 19422761.
      View in: PubMed   Mentions: 87     Fields:    Translation:HumansCells
    228. IDENTIFYING PATTERNS OF COPY NUMBER VARIANTS IN CASE-CONTROL STUDIES OF HUMAN GENETIC DISORDERS. . 2009 May 1; 1-4. Abdullah K. Alqallaf, Ahmed H. Tewfik, Paula Krakowiak, Flora Tassone, Ryan Davis, Robin Hansen, Irva Hertz-Picciotto, Isaac Pessah, Jeff Gregg, Scott B. Selleck. .
      View in: Publisher Site   Mentions:
    229. Catechol-O-methyltransferase polymorphism modulates cognitive control in children with chromosome 22q11.2 deletion syndrome. Cogn Affect Behav Neurosci. 2009 Mar; 9(1):83-90. Takarae Y, Schmidt L, Tassone F, Simon TJ. PMID: 19246329.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansCells
    230. A solution to limitations of cognitive testing in children with intellectual disabilities: the case of fragile X syndrome. J Neurodev Disord. 2009 Mar; 1(1):33-45. Hessl D, Nguyen DV, Green C, Chavez A, Tassone F, Hagerman RJ, Senturk D, Schneider A, Lightbody A, Reiss AL, Hall S. PMID: 19865612.
      View in: PubMed   Mentions: 55     Fields:    
    231. Screening for the presence of FMR1 premutation alleles in women with parkinsonism. Arch Neurol. 2009 Feb; 66(2):244-9. Cilia R, Kraff J, Canesi M, Pezzoli G, Goldwurm S, Amiri K, Tang HT, Pan R, Hagerman PJ, Tassone F. PMID: 19204162.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    232. Covariate adjusted correlation analysis with application to FMR1 premutation female carrier data. Biometrics. 2009 Sep; 65(3):781-92. Sentürk D, Nguyen DV, Tassone F, Hagerman RJ, Carroll RJ, Hagerman PJ. PMID: 19173699.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    233. Autism profiles of males with fragile X syndrome. Am J Ment Retard. 2008 Nov; 113(6):427-38. Harris SW, Hessl D, Goodlin-Jones B, Ferranti J, Bacalman S, Barbato I, Tassone F, Hagerman PJ, Herman H, Hagerman RJ. PMID: 19127654.
      View in: PubMed   Mentions: 144     Fields:    Translation:Humans
    234. Secondary medical diagnosis in fragile X syndrome with and without autism spectrum disorder. Am J Med Genet A. 2008 Aug 01; 146A(15):1911-6. García-Nonell C, Ratera ER, Harris S, Hessl D, Ono MY, Tartaglia N, Marvin E, Tassone F, Hagerman RJ. PMID: 18627038.
      View in: PubMed   Mentions: 38     Fields:    Translation:HumansCells
    235. Clinical and neuropathologic findings in a woman with the FMR1 premutation and multiple sclerosis. Arch Neurol. 2008 Aug; 65(8):1114-6. Greco CM, Tassone F, Garcia-Arocena D, Tartaglia N, Coffey SM, Vartanian TK, Brunberg JA, Hagerman PJ, Hagerman RJ. PMID: 18695063.
      View in: PubMed   Mentions: 28     Fields:    Translation:Humans
    236. Reduced telomere length in older men with premutation alleles of the fragile X mental retardation 1 gene. Am J Med Genet A. 2008 Jun 15; 146A(12):1543-6. Jenkins EC, Tassone F, Ye L, Gu H, Xi M, Velinov M, Brown WT, Hagerman RJ, Hagerman PJ. PMID: 18478592.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCells
    237. Expanded clinical phenotype of women with the FMR1 premutation. Am J Med Genet A. 2008 Apr 15; 146A(8):1009-16. Coffey SM, Cook K, Tartaglia N, Tassone F, Nguyen DV, Pan R, Bronsky HE, Yuhas J, Borodyanskaya M, Grigsby J, Doerflinger M, Hagerman PJ, Hagerman RJ. PMID: 18348275.
      View in: PubMed   Mentions: 133     Fields:    Translation:HumansCells
    238. A girl with fragile X premutation from sperm donation. Am J Med Genet A. 2008 Apr 01; 146A(7):888-92. Wirojanan J, Angkustsiri K, Tassone F, Gane LW, Hagerman RJ. PMID: 18286596.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    239. Abnormal nerve conduction features in fragile X premutation carriers. Arch Neurol. 2008 Apr; 65(4):495-8. Soontarapornchai K, Maselli R, Fenton-Farrell G, Tassone F, Hagerman PJ, Hessl D, Hagerman RJ. PMID: 18413472.
      View in: PubMed   Mentions: 31     Fields:    Translation:HumansCells
    240. Two boys with fragile x syndrome and hepatic tumors. J Pediatr Hematol Oncol. 2008 Mar; 30(3):239-41. Wirojanan J, Kraff J, Hawkins DS, Laird C, Gane LW, Angkustsiri K, Tassone F, Hagerman RJ. PMID: 18376289.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    241. A quantitative assessment of tremor and ataxia in FMR1 premutation carriers using CATSYS. Am J Med Genet A. 2008 Mar 01; 146A(5):629-35. Aguilar D, Sigford KE, Soontarapornchai K, Nguyen DV, Adams PE, Yuhas JM, Tassone F, Hagerman PJ, Hagerman RJ. PMID: 18241072.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    242. The primary cognitive deficit among males with fragile X-associated tremor/ataxia syndrome (FXTAS) is a dysexecutive syndrome. J Clin Exp Neuropsychol. 2008 Nov; 30(8):853-69. Brega AG, Goodrich G, Bennett RE, Hessl D, Engle K, Leehey MA, Bounds LS, Paulich MJ, Hagerman RJ, Hagerman PJ, Cogswell JB, Tassone F, Reynolds A, Kooken R, Kenny M, Grigsby J. PMID: 18608667.
      View in: PubMed   Mentions: 43     Fields:    Translation:Humans
    243. Reduced Hippocampal Activation During Recall is Associated with Elevated FMR1 mRNA and Psychiatric Symptoms in Men with the Fragile X Premutation. Brain Imaging Behav. 2008 Jan 18; 2(2):105-116. Koldewyn K, Hessl D, Adams J, Tassone F, Hagerman PJ, Hagerman RJ, Rivera SM. PMID: 19430586.
      View in: PubMed   Mentions: 35     Fields:    
    244. Cognitive profile of fragile X premutation carriers with and without fragile X-associated tremor/ataxia syndrome. Neuropsychology. 2008 Jan; 22(1):48-60. Grigsby J, Brega AG, Engle K, Leehey MA, Hagerman RJ, Tassone F, Hessl D, Hagerman PJ, Cogswell JB, Bennett RE, Cook K, Hall DA, Bounds LS, Paulich MJ, Reynolds A. PMID: 18211155.
      View in: PubMed   Mentions: 78     Fields:    Translation:HumansCells
    245. A rapid polymerase chain reaction-based screening method for identification of all expanded alleles of the fragile X (FMR1) gene in newborn and high-risk populations. J Mol Diagn. 2008 Jan; 10(1):43-9. Tassone F, Pan R, Amiri K, Taylor AK, Hagerman PJ. PMID: 18165273.
      View in: PubMed   Mentions: 162     Fields:    Translation:HumansCells
    246. FMR1 CGG repeat length predicts motor dysfunction in premutation carriers. Neurology. 2008 Apr 15; 70(16 Pt 2):1397-402. Leehey MA, Berry-Kravis E, Goetz CG, Zhang L, Hall DA, Li L, Rice CD, Lara R, Cogswell J, Reynolds A, Gane L, Jacquemont S, Tassone F, Grigsby J, Hagerman RJ, Hagerman PJ. PMID: 18057320.
      View in: PubMed   Mentions: 74     Fields:    Translation:HumansCells
    247. A low symptomatic form of neurodegeneration in younger carriers of the FMR1 premutation, manifesting typical radiological changes. J Med Genet. 2008 Mar; 45(3):179-81. Loesch DZ, Cook M, Litewka L, Gould E, Churchyard A, Tassone F, Slater HR, Storey E. PMID: 18057083.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCells
    248. Fragile X-associated tremor/ataxia syndrome: clinical features, genetics, and testing guidelines. Mov Disord. 2007 Oct 31; 22(14):2018-30, quiz 2140. Berry-Kravis E, Abrams L, Coffey SM, Hall DA, Greco C, Gane LW, Grigsby J, Bourgeois JA, Finucane B, Jacquemont S, Brunberg JA, Zhang L, Lin J, Tassone F, Hagerman PJ, Hagerman RJ, Leehey MA. PMID: 17618523.
      View in: PubMed   Mentions: 111     Fields:    Translation:Humans
    249. An antisense transcript spanning the CGG repeat region of FMR1 is upregulated in premutation carriers but silenced in full mutation individuals. Hum Mol Genet. 2007 Dec 15; 16(24):3174-87. Ladd PD, Smith LE, Rabaia NA, Moore JM, Georges SA, Hansen RS, Hagerman RJ, Tassone F, Tapscott SJ, Filippova GN. PMID: 17921506.
      View in: PubMed   Mentions: 121     Fields:    Translation:HumansAnimalsCells
    250. Neuropathy as a presenting feature in fragile X-associated tremor/ataxia syndrome. Am J Med Genet A. 2007 Oct 01; 143A(19):2256-60. Hagerman RJ, Coffey SM, Maselli R, Soontarapornchai K, Brunberg JA, Leehey MA, Zhang L, Gane LW, Fenton-Farrell G, Tassone F, Hagerman PJ. PMID: 17726686.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    251. Volumetric brain changes in females with fragile X-associated tremor/ataxia syndrome (FXTAS). Neurology. 2007 Aug 28; 69(9):851-9. Adams JS, Adams PE, Nguyen D, Brunberg JA, Tassone F, Zhang W, Koldewyn K, Rivera SM, Grigsby J, Zhang L, DeCarli C, Hagerman PJ, Hagerman RJ. PMID: 17724287.
      View in: PubMed   Mentions: 77     Fields:    Translation:HumansCells
    252. Cognitive, anxiety and mood disorders in the fragile X-associated tremor/ataxia syndrome. Gen Hosp Psychiatry. 2007 Jul-Aug; 29(4):349-56. Bourgeois JA, Cogswell JB, Hessl D, Zhang L, Ono MY, Tassone F, Farzin F, Brunberg JA, Grigsby J, Hagerman RJ. PMID: 17591512.
      View in: PubMed   Mentions: 38     Fields:    Translation:Humans
    253. Screen for excess FMR1 premutation alleles among males with parkinsonism. Arch Neurol. 2007 Jul; 64(7):1002-6. Kraff J, Tang HT, Cilia R, Canesi M, Pezzoli G, Goldwurm S, Hagerman PJ, Tassone F. PMID: 17620491.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansCells
    254. CGG repeat length correlates with age of onset of motor signs of the fragile X-associated tremor/ataxia syndrome (FXTAS). Am J Med Genet B Neuropsychiatr Genet. 2007 Jun 05; 144B(4):566-9. Tassone F, Adams J, Berry-Kravis EM, Cohen SS, Brusco A, Leehey MA, Li L, Hagerman RJ, Hagerman PJ. PMID: 17427188.
      View in: PubMed   Mentions: 64     Fields:    Translation:HumansCells
    255. Impairment of executive cognitive functioning in males with fragile X-associated tremor/ataxia syndrome. Mov Disord. 2007 Apr 15; 22(5):645-50. Grigsby J, Brega AG, Leehey MA, Goodrich GK, Jacquemont S, Loesch DZ, Cogswell JB, Epstein J, Wilson R, Jardini T, Gould E, Bennett RE, Hessl D, Cohen S, Cook K, Tassone F, Hagerman PJ, Hagerman RJ. PMID: 17266074.
      View in: PubMed   Mentions: 39     Fields:    Translation:HumansCells
    256. The Prader-Willi phenotype of fragile X syndrome. J Dev Behav Pediatr. 2007 Apr; 28(2):133-8. Nowicki ST, Tassone F, Ono MY, Ferranti J, Croquette MF, Goodlin-Jones B, Hagerman RJ. PMID: 17435464.
      View in: PubMed   Mentions: 50     Fields:    Translation:HumansCells
    257. Brief report: aggression and stereotypic behavior in males with fragile X syndrome--moderating secondary genes in a "single gene" disorder. J Autism Dev Disord. 2008 Jan; 38(1):184-9. Hessl D, Tassone F, Cordeiro L, Koldewyn K, McCormick C, Green C, Wegelin J, Yuhas J, Hagerman RJ. PMID: 17340199.
      View in: PubMed   Mentions: 28     Fields:    Translation:HumansCells
    258. Elevated FMR1 mRNA in premutation carriers is due to increased transcription. RNA. 2007 Apr; 13(4):555-62. Tassone F, Beilina A, Carosi C, Albertosi S, Bagni C, Li L, Glover K, Bentley D, Hagerman PJ. PMID: 17283214.
      View in: PubMed   Mentions: 89     Fields:    Translation:Cells
    259. Early acceleration of head circumference in children with fragile x syndrome and autism. J Dev Behav Pediatr. 2007 Feb; 28(1):31-5. Chiu S, Wegelin JA, Blank J, Jenkins M, Day J, Hessl D, Tassone F, Hagerman R. PMID: 17353729.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    260. Progression of tremor and ataxia in male carriers of the FMR1 premutation. Mov Disord. 2007 Jan 15; 22(2):203-6. Leehey MA, Berry-Kravis E, Min SJ, Hall DA, Rice CD, Zhang L, Grigsby J, Greco CM, Reynolds A, Lara R, Cogswell J, Jacquemont S, Hessl DR, Tassone F, Hagerman R, Hagerman PJ. PMID: 17133502.
      View in: PubMed   Mentions: 55     Fields:    Translation:HumansCells
    261. Neuropathic features in fragile X premutation carriers. Am J Med Genet A. 2007 Jan 01; 143A(1):19-26. Berry-Kravis E, Goetz CG, Leehey MA, Hagerman RJ, Zhang L, Li L, Nguyen D, Hall DA, Tartaglia N, Cogswell J, Tassone F, Hagerman PJ. PMID: 17152065.
      View in: PubMed   Mentions: 52     Fields:    Translation:HumansCellsPHPublic Health
    262. Tremor/ataxia syndrome and fragile X premutation: diagnostic caveats. J Clin Neurosci. 2007 Mar; 14(3):245-8. Loesch DZ, Litewka L, Churchyard A, Gould E, Tassone F, Cook M. PMID: 17194594.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    263. Amygdala dysfunction in men with the fragile X premutation. Brain. 2007 Feb; 130(Pt 2):404-16. Hessl D, Rivera S, Koldewyn K, Cordeiro L, Adams J, Tassone F, Hagerman PJ, Hagerman RJ. PMID: 17166860.
      View in: PubMed   Mentions: 66     Fields:    Translation:Humans
    264. Molecular and cognitive predictors of the continuum of autistic behaviours in fragile X. Neurosci Biobehav Rev. 2007; 31(3):315-26. Loesch DZ, Bui QM, Dissanayake C, Clifford S, Gould E, Bulhak-Paterson D, Tassone F, Taylor AK, Hessl D, Hagerman R, Huggins RM. PMID: 17097142.
      View in: PubMed   Mentions: 58     Fields:    Translation:Humans
    265. Molecular and imaging correlates of the fragile X-associated tremor/ataxia syndrome. Neurology. 2006 Oct 24; 67(8):1426-31. Cohen S, Masyn K, Adams J, Hessl D, Rivera S, Tassone F, Brunberg J, DeCarli C, Zhang L, Cogswell J, Loesch D, Leehey M, Grigsby J, Hagerman PJ, Hagerman R. PMID: 17060569.
      View in: PubMed   Mentions: 61     Fields:    Translation:HumansCells
    266. Cognitive impairment in a 65-year-old male with the fragile X-associated tremor-ataxia syndrome (FXTAS). Cogn Behav Neurol. 2006 Sep; 19(3):165-71. Grigsby J, Leehey MA, Jacquemont S, Brunberg JA, Hagerman RJ, Wilson R, Epstein JH, Greco CM, Tassone F, Hagerman PJ. PMID: 16957495.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansCells
    267. Transcript levels of the intermediate size or grey zone fragile X mental retardation 1 alleles are raised, and correlate with the number of CGG repeats. J Med Genet. 2007 Mar; 44(3):200-4. Loesch DZ, Bui QM, Huggins RM, Mitchell RJ, Hagerman RJ, Tassone F. PMID: 16905681.
      View in: PubMed   Mentions: 40     Fields:    Translation:HumansCells
    268. Impairment in the cognitive functioning of men with fragile X-associated tremor/ataxia syndrome (FXTAS). J Neurol Sci. 2006 Oct 25; 248(1-2):227-33. Grigsby J, Brega AG, Jacquemont S, Loesch DZ, Leehey MA, Goodrich GK, Hagerman RJ, Epstein J, Wilson R, Cogswell JB, Jardini T, Tassone F, Hagerman PJ. PMID: 16780889.
      View in: PubMed   Mentions: 61     Fields:    Translation:Humans
    269. Autism spectrum disorders and attention-deficit/hyperactivity disorder in boys with the fragile X premutation. J Dev Behav Pediatr. 2006 Apr; 27(2 Suppl):S137-44. Farzin F, Perry H, Hessl D, Loesch D, Cohen J, Bacalman S, Gane L, Tassone F, Hagerman P, Hagerman R. PMID: 16685180.
      View in: PubMed   Mentions: 139     Fields:    Translation:HumansCells
    270. Psychiatric phenotype of the fragile X-associated tremor/ataxia syndrome (FXTAS) in males: newly described fronto-subcortical dementia. J Clin Psychiatry. 2006 Jan; 67(1):87-94. Bacalman S, Farzin F, Bourgeois JA, Cogswell J, Goodlin-Jones BL, Gane LW, Grigsby J, Leehey MA, Tassone F, Hagerman RJ. PMID: 16426093.
      View in: PubMed   Mentions: 67     Fields:    Translation:Humans
    271. Dementia with mood symptoms in a fragile X premutation carrier with the fragile X-associated tremor/ataxia syndrome: clinical intervention with donepezil and venlafaxine. J Neuropsychiatry Clin Neurosci. 2006; 18(2):171-7. Bourgeois JA, Farzin F, Brunberg JA, Tassone F, Hagerman P, Zhang L, Hessl D, Hagerman R. PMID: 16720793.
      View in: PubMed   Mentions: 23     Fields:    Translation:HumansCells
    272. Neuropathology of fragile X-associated tremor/ataxia syndrome (FXTAS). Brain. 2006 Jan; 129(Pt 1):243-55. Greco CM, Berman RF, Martin RM, Tassone F, Schwartz PH, Chang A, Trapp BD, Iwahashi C, Brunberg J, Grigsby J, Hessl D, Becker EJ, Papazian J, Leehey MA, Hagerman RJ, Hagerman PJ. PMID: 16332642.
      View in: PubMed   Mentions: 201     Fields:    Translation:HumansCells
    273. Abnormal elevation of FMR1 mRNA is associated with psychological symptoms in individuals with the fragile X premutation. Am J Med Genet B Neuropsychiatr Genet. 2005 Nov 05; 139B(1):115-21. Hessl D, Tassone F, Loesch DZ, Berry-Kravis E, Leehey MA, Gane LW, Barbato I, Rice C, Gould E, Hall DA, Grigsby J, Wegelin JA, Harris S, Lewin F, Weinberg D, Hagerman PJ, Hagerman RJ. PMID: 16184602.
      View in: PubMed   Mentions: 111     Fields:    Translation:HumansCells
    274. An enhanced polymerase chain reaction assay to detect pre- and full mutation alleles of the fragile X mental retardation 1 gene. J Mol Diagn. 2005 Nov; 7(5):605-12. Saluto A, Brussino A, Tassone F, Arduino C, Cagnoli C, Pappi P, Hagerman P, Migone N, Brusco A. PMID: 16258159.
      View in: PubMed   Mentions: 47     Fields:    Translation:HumansCells
    275. Protein composition of the intranuclear inclusions of FXTAS. Brain. 2006 Jan; 129(Pt 1):256-71. Iwahashi CK, Yasui DH, An HJ, Greco CM, Tassone F, Nannen K, Babineau B, Lebrilla CB, Hagerman RJ, Hagerman PJ. PMID: 16246864.
      View in: PubMed   Mentions: 136     Fields:    Translation:HumansCells
    276. Induction of inclusion formation and disruption of lamin A/C structure by premutation CGG-repeat RNA in human cultured neural cells. Hum Mol Genet. 2005 Dec 01; 14(23):3661-71. Arocena DG, Iwahashi CK, Won N, Beilina A, Ludwig AL, Tassone F, Schwartz PH, Hagerman PJ. PMID: 16239243.
      View in: PubMed   Mentions: 79     Fields:    Translation:HumansCells
    277. Expression profiling suggests underexpression of the GABA(A) receptor subunit delta in the fragile X knockout mouse model. Neurobiol Dis. 2006 Feb; 21(2):346-57. Gantois I, Vandesompele J, Speleman F, Reyniers E, D'Hooge R, Severijnen LA, Willemsen R, Tassone F, Kooy RF. PMID: 16199166.
      View in: PubMed   Mentions: 61     Fields:    Translation:HumansAnimals
    278. Magnetic resonance imaging study in older fragile X premutation male carriers. Ann Neurol. 2005 Aug; 58(2):326-30. Loesch DZ, Litewka L, Brotchie P, Huggins RM, Tassone F, Cook M. PMID: 16049924.
      View in: PubMed   Mentions: 22     Fields:    Translation:HumansCells
    279. No evidence of paternal transmission of fragile X syndrome. Am J Med Genet A. 2005 Jul 01; 136(1):107-8; author reply 109-10. Steinbach D, Steinbach P. PMID: 15887276.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    280. Evidence for, and a spectrum of, neurological involvement in carriers of the fragile X pre-mutation: FXTAS and beyond. Clin Genet. 2005 May; 67(5):412-7. Loesch DZ, Churchyard A, Brotchie P, Marot M, Tassone F. PMID: 15811008.
      View in: PubMed   Mentions: 26     Fields:    Translation:HumansCells
    281. Spastic paraparesis, cerebellar ataxia, and intention tremor: a severe variant of FXTAS? J Med Genet. 2005 Feb; 42(2):e14. Jacquemont S, Orrico A, Galli L, Sahota PK, Brunberg JA, Anichini C, Leehey M, Schaeffer S, Hagerman RJ, Hagerman PJ, Tassone F. PMID: 15689437.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    282. Neural progenitor cells from an adult patient with fragile X syndrome. BMC Med Genet. 2005 Jan 14; 6:2. Schwartz PH, Tassone F, Greco CM, Nethercott HE, Ziaeian B, Hagerman RJ, Hagerman PJ. PMID: 15649335.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    283. GRAND ROUNDS: an atypical progressive dementia in a male carrier of the fragile X premutation: an example of fragile X-associated tremor/ataxia syndrome. Appl Neuropsychol. 2005; 12(3):169-78. Mothersead PK, Conrad K, Hagerman RJ, Greco CM, Hessl D, Tassone F. PMID: 16131344.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    284. Autistic spectrum disorder and the fragile X premutation. J Dev Behav Pediatr. 2004 Dec; 25(6):392-8. Goodlin-Jones BL, Tassone F, Gane LW, Hagerman RJ. PMID: 15613987.
      View in: PubMed   Mentions: 53     Fields:    Translation:HumansPHPublic Health
    285. The effect of pre-mutation of X chromosome CGG trinucleotide repeats on brain anatomy. Brain. 2004 Dec; 127(Pt 12):2672-81. Moore CJ, Daly EM, Tassone F, Tysoe C, Schmitz N, Ng V, Chitnis X, McGuire P, Suckling J, Davies KE, Hagerman RJ, Hagerman PJ, Murphy KC, Murphy DG. PMID: 15483045.
      View in: PubMed   Mentions: 25     Fields:    Translation:HumansCells
    286. Paternal transmission of fragile X syndrome. Am J Med Genet A. 2004 Aug 30; 129A(2):184-9. Zeesman S, Zwaigenbaum L, Whelan DT, Hagerman RJ, Tassone F, Taylor SA. PMID: 15316964.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCells
    287. Screen for expanded FMR1 alleles in patients with essential tremor. Mov Disord. 2004 Aug; 19(8):930-3. Garcia Arocena D, Louis ED, Tassone F, Gilliam TC, Ottman R, Jacquemont S, Hagerman PJ. PMID: 15300658.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCells
    288. FMR1 RNA within the intranuclear inclusions of fragile X-associated tremor/ataxia syndrome (FXTAS). RNA Biol. 2004 Jul; 1(2):103-5. Tassone F, Iwahashi C, Hagerman PJ. PMID: 17179750.
      View in: PubMed   Mentions: 113     Fields:    Translation:HumansCells
    289. Fragile-X-associated tremor/ataxia syndrome (FXTAS) in females with the FMR1 premutation. Am J Hum Genet. 2004 May; 74(5):1051-6. Hagerman RJ, Leavitt BR, Farzin F, Jacquemont S, Greco CM, Brunberg JA, Tassone F, Hessl D, Harris SW, Zhang L, Jardini T, Gane LW, Ferranti J, Ruiz L, Leehey MA, Grigsby J, Hagerman PJ. PMID: 15065016.
      View in: PubMed   Mentions: 95     Fields:    Translation:HumansCells
    290. Intranuclear inclusions in neural cells with premutation alleles in fragile X associated tremor/ataxia syndrome. J Med Genet. 2004 Apr; 41(4):e43. Tassone F, Hagerman RJ, Garcia-Arocena D, Khandjian EW, Greco CM, Hagerman PJ. PMID: 15060119.
      View in: PubMed   Mentions: 63     Fields:    Translation:HumansCells
    291. Aging in individuals with the FMR1 mutation. Am J Ment Retard. 2004 Mar; 109(2):154-64. Jacquemont S, Farzin F, Hall D, Leehey M, Tassone F, Gane L, Zhang L, Grigsby J, Jardini T, Lewin F, Berry-Kravis E, Hagerman PJ, Hagerman RJ. PMID: 15000674.
      View in: PubMed   Mentions: 48     Fields:    Translation:Humans
    292. Penetrance of the fragile X-associated tremor/ataxia syndrome in a premutation carrier population. JAMA. 2004 Jan 28; 291(4):460-9. Jacquemont S, Hagerman RJ, Leehey MA, Hall DA, Levine RA, Brunberg JA, Zhang L, Jardini T, Gane LW, Harris SW, Herman K, Grigsby J, Greco CM, Berry-Kravis E, Tassone F, Hagerman PJ. PMID: 14747503.
      View in: PubMed   Mentions: 197     Fields:    Translation:HumansCells
    293. Redistribution of transcription start sites within the FMR1 promoter region with expansion of the downstream CGG-repeat element. Hum Mol Genet. 2004 Mar 01; 13(5):543-9. Beilina A, Tassone F, Schwartz PH, Sahota P, Hagerman PJ. PMID: 14722156.
      View in: PubMed   Mentions: 33     Fields:    Translation:HumansCells
    294. A neuropsychological investigation of male premutation carriers of fragile X syndrome. Neuropsychologia. 2004; 42(14):1934-47. Moore CJ, Daly EM, Schmitz N, Tassone F, Tysoe C, Hagerman RJ, Hagerman PJ, Morris RG, Murphy KC, Murphy DG. PMID: 15381024.
      View in: PubMed   Mentions: 42     Fields:    Translation:HumansCells
    295. The (CGG)n repeat element within the 5' untranslated region of the FMR1 message provides both positive and negative cis effects on in vivo translation of a downstream reporter. Hum Mol Genet. 2003 Dec 01; 12(23):3067-74. Chen LS, Tassone F, Sahota P, Hagerman PJ. PMID: 14519687.
      View in: PubMed   Mentions: 55     Fields:    Translation:HumansCells
    296. The FMR1 CGG repeat mouse displays ubiquitin-positive intranuclear neuronal inclusions; implications for the cerebellar tremor/ataxia syndrome. Hum Mol Genet. 2003 May 01; 12(9):949-59. Willemsen R, Hoogeveen-Westerveld M, Reis S, Holstege J, Severijnen LA, Nieuwenhuizen IM, Schrier M, van Unen L, Tassone F, Hoogeveen AT, Hagerman PJ, Mientjes EJ, Oostra BA. PMID: 12700164.
      View in: PubMed   Mentions: 119     Fields:    Translation:HumansAnimalsCells
    297. Fragile X premutation tremor/ataxia syndrome: molecular, clinical, and neuroimaging correlates. Am J Hum Genet. 2003 Apr; 72(4):869-78. Jacquemont S, Hagerman RJ, Leehey M, Grigsby J, Zhang L, Brunberg JA, Greco C, Des Portes V, Jardini T, Levine R, Berry-Kravis E, Brown WT, Schaeffer S, Kissel J, Tassone F, Hagerman PJ. PMID: 12638084.
      View in: PubMed   Mentions: 240     Fields:    Translation:Humans
    298. Expression of the FMR1 gene. Cytogenet Genome Res. 2003; 100(1-4):124-8. Tassone F, Hagerman PJ. PMID: 14526172.
      View in: PubMed   Mentions: 24     Fields:    Translation:HumansCells
    299. The fragile X premutation presenting as essential tremor. Arch Neurol. 2003 Jan; 60(1):117-21. Leehey MA, Munhoz RP, Lang AE, Brunberg JA, Grigsby J, Greco C, Jacquemont S, Tassone F, Lozano AM, Hagerman PJ, Hagerman RJ. PMID: 12533098.
      View in: PubMed   Mentions: 31     Fields:    Translation:Humans
    300. Reduced FMR1 mRNA translation efficiency in fragile X patients with premutations. RNA. 2002 Dec; 8(12):1482-8. Primerano B, Tassone F, Hagerman RJ, Hagerman P, Amaldi F, Bagni C. PMID: 12515381.
      View in: PubMed   Mentions: 77     Fields:    Translation:HumansCells
    301. Fragile X premutation carriers: characteristic MR imaging findings of adult male patients with progressive cerebellar and cognitive dysfunction. AJNR Am J Neuroradiol. 2002 Nov-Dec; 23(10):1757-66. Brunberg JA, Jacquemont S, Hagerman RJ, Berry-Kravis EM, Grigsby J, Leehey MA, Tassone F, Brown WT, Greco CM, Hagerman PJ. PMID: 12427636.
      View in: PubMed   Mentions: 110     Fields:    Translation:HumansCells
    302. Neuronal intranuclear inclusions in a new cerebellar tremor/ataxia syndrome among fragile X carriers. Brain. 2002 Aug; 125(Pt 8):1760-71. Greco CM, Hagerman RJ, Tassone F, Chudley AE, Del Bigio MR, Jacquemont S, Leehey M, Hagerman PJ. PMID: 12135967.
      View in: PubMed   Mentions: 189     Fields:    Translation:HumansCells
    303. Tremor/Ataxia syndrome in fragile X carrier males. Movement Disorders. 2002 Jul 1; 17(4):744-745. Maureen A. Leehey, Randi J. Hagerman, William M. Landau, Jim Grigsby, Flora Tassone, Paul J. Hagerman. .
      View in: Publisher Site   Mentions:
    304. Intention tremor, parkinsonism, and generalized brain atrophy in male carriers of fragile X. Neurology. 2001 Jul 10; 57(1):127-30. Hagerman RJ, Leehey M, Heinrichs W, Tassone F, Wilson R, Hills J, Grigsby J, Gage B, Hagerman PJ. PMID: 11445641.
      View in: PubMed   Mentions: 287     Fields:    Translation:Humans
    305. A majority of fragile X males with methylated, full mutation alleles have significant levels of FMR1 messenger RNA. J Med Genet. 2001 Jul; 38(7):453-6. Tassone F, Hagerman RJ, Taylor AK, Hagerman PJ. PMID: 11432964.
      View in: PubMed   Mentions: 33     Fields:    Translation:HumansCells
    306. Variability in FMRP and early development in males with fragile X syndrome. Am J Ment Retard. 2001 Jan; 106(1):16-27. Bailey DB, Hatton DD, Tassone F, Skinner M, Taylor AK. PMID: 11246709.
      View in: PubMed   Mentions: 23     Fields:    Translation:Humans
    307. Fragile X males with unmethylated, full mutation trinucleotide repeat expansions have elevated levels of FMR1 messenger RNA. Am J Med Genet. 2000 Sep 18; 94(3):232-6. Tassone F, Hagerman RJ, Loesch DZ, Lachiewicz A, Taylor AK, Hagerman PJ. PMID: 10995510.
      View in: PubMed   Mentions: 60     Fields:    Translation:HumansCells
    308. Clinical involvement and protein expression in individuals with the FMR1 premutation. Am J Med Genet. 2000 Mar 13; 91(2):144-52. Tassone F, Hagerman RJ, Taylor AK, Mills JB, Harris SW, Gane LW, Hagerman PJ. PMID: 10748416.
      View in: PubMed   Mentions: 83     Fields:    Translation:HumansCells
    309. Elevated levels of FMR1 mRNA in carrier males: a new mechanism of involvement in the fragile-X syndrome. Am J Hum Genet. 2000 Jan; 66(1):6-15. Tassone F, Hagerman RJ, Taylor AK, Gane LW, Godfrey TE, Hagerman PJ. PMID: 10631132.
      View in: PubMed   Mentions: 311     Fields:    Translation:HumansCells
    310. Transcription of the FMR1 gene in individuals with fragile X syndrome. Am J Med Genet. 2000; 97(3):195-203. Tassone F, Hagerman RJ, Chamberlain WD, Hagerman PJ. PMID: 11449488.
      View in: PubMed   Mentions: 72     Fields:    Translation:HumansCells
    311. Fragile X syndrome and an isodicentric X chromosome in a woman with multiple anomalies, developmental delay, and normal pubertal development. Am J Med Genet. 1999 Jul 30; 85(3):197-201. Freedenberg DL, Gane LW, Richards CS, Lampe M, Hills J, O'Connor R, Manchester D, Taylor A, Tassone F, Hulseberg D, Hagerman RJ, Patil SR. PMID: 10398226.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    312. Tissue heterogeneity of the FMR1 mutation in a high-functioning male with fragile X syndrome. Am J Med Genet. 1999 May 28; 84(3):233-9. Taylor AK, Tassone F, Dyer PN, Hersch SM, Harris JB, Greenough WT, Hagerman RJ. PMID: 10331599.
      View in: PubMed   Mentions: 23     Fields:    Translation:HumansCells
    313. Strong similarities of the FMR1 mutation in multiple tissues: postmortem studies of a male with a full mutation and a male carrier of a premutation. Am J Med Genet. 1999 May 28; 84(3):240-4. Tassone F, Hagerman RJ, Gane LW, Taylor AK. PMID: 10331600.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    314. FMRP expression as a potential prognostic indicator in fragile X syndrome. Am J Med Genet. 1999 May 28; 84(3):250-61. Tassone F, Hagerman RJ, Iklé DN, Dyer PN, Lampe M, Willemsen R, Oostra BA, Taylor AK. PMID: 10331602.
      View in: PubMed   Mentions: 84     Fields:    Translation:Humans
    315. Tissue-specific methylation differences in a fragile X premutation carrier. Clin Genet. 1999 May; 55(5):346-51. Tassone F, Longshore J, Zunich J, Steinbach P, Salat U, Taylor AK. PMID: 10422805.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCells
    316. Electrodermal responses to sensory stimuli in individuals with fragile X syndrome: a preliminary report. Am J Med Genet. 1999 Apr 02; 83(4):268-79. Miller LJ, McIntosh DN, McGrath J, Shyu V, Lampe M, Taylor AK, Tassone F, Neitzel K, Stackhouse T, Hagerman RJ. PMID: 10208160.
      View in: PubMed   Mentions: 114     Fields:    Translation:Humans
    317. Compound heterozygous female with fragile X syndrome. Am J Med Genet. 1999 Apr 02; 83(4):318-21. Linden MG, Tassone F, Gane LW, Hills JL, Hagerman RJ, Taylor AK. PMID: 10208169.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    318. Structures, sequence characteristics, and synteny relationships of the transcription factor E4TF1, the splicing factor U2AF35 and the cystathionine beta synthetase genes from Fugu rubripes. Gene. 1999 Jan 21; 226(2):211-23. Tassone F, Villard L, Clancy K, Gardiner K. PMID: 9931491.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansAnimalsCells
    319. Gene expression relevant to Down syndrome: problems and approaches. J Neural Transm Suppl. 1999; 57:179-95. Tassone F, Lucas R, Slavov D, Kavsan V, Crnic L, Gardiner K. PMID: 10666675.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansAnimalsCells
    320. Construction of a 2.5-Mb integrated physical and gene map of distal 21q22.3. Genomics. 1998 Apr 01; 49(1):1-13. Lapenta V, Sossi V, Gosset P, Vayssettes C, Vitali T, Rabatel N, Tassone F, Blouin JL, Scott HS, Antonarakis SE, Créau N, Brahe C. PMID: 9570943.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    321. Analysis of pufferfish homologues of the AT-rich human APP gene. Gene. 1998 Mar 27; 210(1):17-24. Villard L, Tassone F, Crnogorac-Jurcevic T, Clancy K, Gardiner K. PMID: 9599080.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansAnimalsCells
    322. Map location, genomic organization and expression patterns of the human RED1 RNA editase. Somat Cell Mol Genet. 1997 Mar; 23(2):135-45. Villard L, Tassone F, Haymowicz M, Welborn R, Gardiner K. PMID: 9330641.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansAnimalsCells
    323. cDNA selection from 10 Mb of chromosome 21 DNA: efficiency in transcriptional mapping and reflections of genome organization. Hum Mol Genet. 1995 Sep; 4(9):1509-18. Tassone F, Xu H, Burkin H, Weissman S, Gardiner K. PMID: 8541833.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    324. A search for genes from the dark band regions of human chromosome 21. Genomics. 1995 May 01; 27(1):1-8. Xu H, Wei H, Tassone F, Graw S, Gardiner K, Weissman SM. PMID: 7665155.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansAnimalsCells
    325. Highly polymorphic repeat marker within the beta-amyloid precursor protein gene. Hum Genet. 1994 Jan; 93(1):85-6. Zappata S, Petersen MB, König U, Blaschak J, Chakravarti A, Tassone F, Serra A, Antonarakis SE, Brahe C. PMID: 8270262.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    326. Molecular and cytogenetic characterization of a Chinese hamster/human hybrid cell line containing a der (21)t(Ypter-->cenY::cen21-->21qter) chromosome. Genomics. 1993 Jan; 15(1):177-9. Patterson D, Hart I, Lai LW, Brahe C, Moscetti A, Tassone F, Raimondi E, Jones C. PMID: 8432530.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansAnimalsCells
    327. Analysis of chromosome 21 yeast artificial chromosome (YAC) clones. Am J Hum Genet. 1992 Dec; 51(6):1251-64. Tassone F, Cheng S, Gardiner K. PMID: 1463009.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCells
    328. Dinucleotide repeat polymorphism at the D21S65 locus. Hum Mol Genet. 1992 Aug; 1(5):350. Goto J, Tassone F, Demczuk S, Gardiner K, Figlewicz DA, Khodr N, Rouleau GA. PMID: 1303216.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    329. D21S170 maps to terminal 21q22.3. Nucleic Acids Res. 1990 Oct 25; 18(20):6178. Moscetti A, Tassone F, Serra A, Brahe C. PMID: 1978295.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimalsCells
    330. Pericentric inversion of chromosome 9: prevalence in 300 Down syndrome families and molecular studies of nondisjunction. Am J Med Genet Suppl. 1990; 7:162-8. Serra A, Brahe C, Millington-Ward A, Neri G, Tedeschi B, Tassone F, Bova R. PMID: 1981475.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCells
    331. Molecular study of parental origin of extra chromosome 21 in regular and de novo translocation trisomies. Am J Med Genet Suppl. 1990; 7:125-8. Brahe C, Tassone F, Moscetti A, Millington-Ward A, Bova R, Serra A. PMID: 2149938.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    332. Potential gene sequence isolation and regional mapping in human chromosome 21. Am J Med Genet Suppl. 1990; 7:120-4. Brahe C, Tassone F, Millington-Ward A, Serra A, Gardiner K. PMID: 2127361.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansAnimalsCells
    333. Family and population studies of SAHH and ADA polymorphisms. A possible pitfall in the ascertainment of SAHH electrophoretic phenotypes. Ann Hum Genet. 1987 10; 51(4):295-302. Scozzari R, Sellitto D, Tassone F, Cerroni L, Aliquò MC. PMID: 3447513.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    Flora's Networks
    Concepts (714)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (50)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _
    ↑